{"gene":"STK39","run_date":"2026-04-28T21:42:57","timeline":{"discoveries":[{"year":2000,"finding":"SPAK (STK39) is a serine/threonine kinase that can autophosphorylate and phosphorylate exogenous substrates in vitro; it specifically activates the p38 MAPK pathway in cotransfection assays; full-length SPAK localizes to the cytoplasm while a caspase-cleaved form localizes predominantly to the nucleus.","method":"In vitro kinase assay, cotransfection/reporter assay, subcellular localization by immunofluorescence","journal":"Oncogene","confidence":"Medium","confidence_rationale":"Tier 2 — in vitro kinase activity plus functional cotransfection and localization data, single lab","pmids":["10980603"],"is_preprint":false},{"year":2002,"finding":"SPAK and OSR1 directly interact with cation-chloride cotransporters KCC3, NKCC1, and NKCC2 (but not KCC1 or KCC4) via a conserved C-terminal domain on the kinases that recognizes an (R/K)FX(V/I) binding motif on the cotransporters; co-immunoprecipitation confirmed the SPAK-NKCC1 interaction in mouse brain.","method":"Yeast two-hybrid, GST pulldown, co-immunoprecipitation, immunohistochemistry","journal":"The Journal of biological chemistry","confidence":"High","confidence_rationale":"Tier 2 — reciprocal interaction confirmed by multiple methods (Y2H, pulldown, Co-IP) in multiple contexts; replicated widely","pmids":["12386165"],"is_preprint":false},{"year":2003,"finding":"SPAK acts as a scaffolding protein at NKCC1: preventing SPAK binding to NKCC1 does not affect basal cotransporter function, but SPAK co-immunoprecipitates with p38 MAPK and NKCC1 in an activity-dependent manner, with p38 dissociating from the complex upon cellular stress while SPAK-NKCC1 interaction remains stable.","method":"86Rb+ uptake assay in Xenopus oocytes, co-immunoprecipitation, Western blot","journal":"The Journal of biological chemistry","confidence":"Medium","confidence_rationale":"Tier 2 — functional and biochemical data from single lab with multiple methods","pmids":["14563843"],"is_preprint":false},{"year":2004,"finding":"PKCθ phosphorylates SPAK on Ser-311 in its kinase domain; SPAK interacts with PKCθ (but not PKCα) via its C-terminal 99 residues; TCR/CD28 costimulation enhances this association and SPAK kinase activity; SPAK synergizes with constitutively active PKCθ to activate AP-1 but not NF-κB in T cells.","method":"Co-immunoprecipitation, in vitro kinase assay, RNAi knockdown, reporter assay","journal":"The EMBO journal","confidence":"High","confidence_rationale":"Tier 1-2 — direct phosphorylation site identified by mutagenesis plus Co-IP and functional reporter assays, moderate evidence","pmids":["14988727"],"is_preprint":false},{"year":2005,"finding":"WNK1 phosphorylates the evolutionary conserved serine residue located outside the kinase domain of SPAK (and OSR1), and this phosphorylation influences SPAK/OSR1 kinase activity; SPAK and OSR1 directly phosphorylate the N-terminal regulatory regions of cation-chloride cotransporters NKCC1, NKCC2, and NCC; hypotonic stress activates SPAK/OSR1 and induces cotransporter phosphorylation.","method":"In vitro kinase assay, cell-based phosphorylation assay, site-directed mutagenesis","journal":"The Journal of biological chemistry","confidence":"High","confidence_rationale":"Tier 1 — direct in vitro phosphorylation with mutagenesis, widely replicated","pmids":["16263722"],"is_preprint":false},{"year":2006,"finding":"SPAK activation loop residues T243 and T247 are required for kinase activity; mutation of T243A or T247A produces a dominant-negative effect on NKCC1 activity in Xenopus oocytes; OSR1 has similar kinase properties and activates NKCC1 when coexpressed with WNK4.","method":"Site-directed mutagenesis, 32P-ATP in vitro phosphorylation, 86Rb+ uptake in Xenopus oocytes","journal":"Molecular and cellular biology","confidence":"High","confidence_rationale":"Tier 1 — activation-loop mutagenesis combined with in vitro and functional assays","pmids":["16382158"],"is_preprint":false},{"year":2006,"finding":"SPAK and OSR1 possess a conserved C-terminal CCT domain that interacts with nanomolar affinity with RFXV motifs in substrates (NKCC1) and upstream activators (WNK1/WNK4); specific residues within the CCT domain are required for RFXV binding; an intact CCT domain is required for WNK1 to efficiently phosphorylate and activate OSR1; SPAK/OSR1 phosphorylate NKCC1 at Thr203/Thr207/Thr212 (human) identified by in vitro assay.","method":"In vitro kinase assay, surface plasmon resonance, CCT domain mutagenesis, peptide competition","journal":"The Biochemical journal","confidence":"High","confidence_rationale":"Tier 1 — reconstitution with quantitative binding measurements and mutagenesis; replicated across multiple labs","pmids":["16669787"],"is_preprint":false},{"year":2006,"finding":"RELT (TNF receptor) binds SPAK via an RFRV motif and uses SPAK to mediate p38 and JNK activation; disruption of the SPAK binding motif in RELT or use of kinase-dead SPAK inhibits RELT-induced p38/JNK activation.","method":"Yeast two-hybrid, co-immunoprecipitation, reporter/kinase activity assay","journal":"Biochemical and biophysical research communications","confidence":"Medium","confidence_rationale":"Tier 3 — single Co-IP plus functional assay, single lab","pmids":["16530727"],"is_preprint":false},{"year":2007,"finding":"Physical docking of SPAK to NKCC1 via a single RFXV binding motif is necessary for cotransporter activation; mutation of the phenylalanine in the motif abolishes binding and activation; SPAK phosphorylates NKCC1 at T206 and T211 as major regulatory sites.","method":"Yeast two-hybrid, 32P-ATP in vitro phosphorylation, 86Rb+ uptake in Xenopus oocytes, site-directed mutagenesis","journal":"Cellular physiology and biochemistry","confidence":"High","confidence_rationale":"Tier 1 — phosphorylation site identification combined with docking mutagenesis and functional assay","pmids":["17595523"],"is_preprint":false},{"year":2007,"finding":"AATYK1 scaffolds protein phosphatase 1 (PP1) via a PP1 docking motif and binds SPAK via RFXV motifs; AATYK1 inhibits NKCC1 activity by bringing PP1 into proximity with SPAK, thereby indirectly opposing SPAK/WNK4 activation of the cotransporter.","method":"Yeast two-hybrid, 86Rb+ uptake in Xenopus oocytes, site-directed mutagenesis","journal":"American journal of physiology. Cell physiology","confidence":"Medium","confidence_rationale":"Tier 2 — functional assay with mutagenesis plus protein-protein interaction data, single lab","pmids":["17267545"],"is_preprint":false},{"year":2008,"finding":"SPAK and OSR1 activated by WNK1 phosphorylate human NCC at Thr46, Thr55, and Thr60; efficient NCC phosphorylation requires a docking interaction between an RFXI motif in NCC and SPAK/OSR1; hypotonic low-chloride conditions activate the WNK1-SPAK/OSR1 pathway to phosphorylate NCC in kidney cells.","method":"In vitro kinase assay, phospho-specific antibodies, cell-based assay in HEK293 and mpkDCT cells, mutagenesis","journal":"Journal of cell science","confidence":"High","confidence_rationale":"Tier 1 — direct phosphorylation sites mapped by mutagenesis and in vitro assay, replicated in cells","pmids":["18270262"],"is_preprint":false},{"year":2008,"finding":"PKCδ acts upstream of SPAK to activate NKCC1 during hyperosmotic stress in airway epithelial cells; PKCδ directly binds SPAK and phosphorylates it to increase SPAK kinase activity; SPAK binds the amino terminus of NKCC1 directly and SPAK knockdown prevents NKCC1 phosphorylation and activation.","method":"siRNA knockdown, recombinant protein binding assay, in vitro kinase assay, 86Rb+ flux assay, co-immunoprecipitation","journal":"The Journal of biological chemistry","confidence":"High","confidence_rationale":"Tier 1-2 — direct binding and in vitro kinase data plus RNAi functional validation with multiple methods","pmids":["18550547"],"is_preprint":false},{"year":2009,"finding":"STK39/SPAK interacts with WNK kinases and cation-chloride cotransporters in vivo; STK39 is expressed in the distal nephron where it may regulate renal Na+ excretion; an intronic conserved element shows allele-specific transcriptional activity, suggesting BP-associated variants increase STK39 expression.","method":"Cell-based co-immunoprecipitation, in vivo expression/localization, in vitro transcription reporter assay","journal":"Proceedings of the National Academy of Sciences of the United States of America","confidence":"Medium","confidence_rationale":"Tier 2-3 — Co-IP interaction confirmed, localization established, functional transcription element tested; single study","pmids":["19114657"],"is_preprint":false},{"year":2009,"finding":"AngII signaling increases NCC activity via a WNK4-SPAK-dependent pathway in Xenopus oocytes and mammalian cells; dominant-negative SPAK or elimination of the SPAK binding motif in NCC prevents AngII-mediated NCC activation; AngII increases phosphorylation of specific activation sites on SPAK and NCC.","method":"Xenopus oocyte expression, dominant-negative SPAK, phospho-specific antibodies in mpkDCT cells","journal":"Proceedings of the National Academy of Sciences of the United States of America","confidence":"High","confidence_rationale":"Tier 2 — epistasis with dominant-negative plus cell-based phosphorylation, replicated in two expression systems","pmids":["19240212"],"is_preprint":false},{"year":2009,"finding":"Epigenetic silencing of STK39 in B-cell lymphoma inhibits caspase-3-dependent apoptosis from DNA double-strand breaks; SPAK knockdown by shRNA protects B cells from genotoxic stress-induced apoptosis but not osmotic/oxidative stress; c-Jun N-terminal kinase (JNK) is a potential downstream mediator of SPAK in this pathway.","method":"shRNA knockdown, apoptosis/caspase-3 assay, pharmacological JNK inhibition, DNA methylation analysis","journal":"The American journal of pathology","confidence":"Medium","confidence_rationale":"Tier 2 — RNAi loss-of-function with specific apoptosis readout and pathway pharmacology, single lab","pmids":["19717643"],"is_preprint":false},{"year":2010,"finding":"SPAK knockout mice exhibit hypotension with Gitelman syndrome phenotype (hypokalemia, hypomagnesemia, hypocalciuria); NCC phosphorylation and expression are markedly reduced while NKCC2 phosphorylation is increased; NKCC1 phosphorylation in aortic tissue is decreased causing impaired vasoconstriction, establishing SPAK as an in vivo regulator of both renal NCC and vascular NKCC1.","method":"SPAK-null mouse model, phospho-specific Western blot, diuretic challenge, vascular contractility assay","journal":"Journal of the American Society of Nephrology : JASN","confidence":"High","confidence_rationale":"Tier 2 — clean knockout with multiple defined phenotypic readouts, replicated by multiple labs","pmids":["20813865"],"is_preprint":false},{"year":2010,"finding":"SPAK knock-in mice in which SPAK cannot be activated by WNK kinases display markedly reduced phosphorylation and expression of NCC and NKCC2 cotransporters and significantly reduced blood pressure, establishing the WNK-SPAK axis as the key in vivo regulatory pathway for these transporters.","method":"Knock-in mouse model (WNK-binding site mutation), phospho-specific Western blot, blood pressure measurement","journal":"EMBO molecular medicine","confidence":"High","confidence_rationale":"Tier 2 — genetic epistasis with clean knock-in, replicated phenotype across multiple groups","pmids":["20091762"],"is_preprint":false},{"year":2010,"finding":"SPAK requires phosphorylation at T243 (catalytic domain) and S383 (regulatory domain) by WNK kinases for activation; mutating S383 to alanine or surrounding residues paradoxically renders SPAK constitutively active; a second catalytic-domain serine S321 can also be phosphorylated by WNK4; SPAK substrate recognition requires two threonines separated by four amino acids with a hydrophobic residue after the first.","method":"Site-directed mutagenesis, 86Rb+ uptake in Xenopus oocytes, in vitro kinase assay","journal":"American journal of physiology. Cell physiology","confidence":"High","confidence_rationale":"Tier 1 — detailed mechanistic mutagenesis combined with functional and in vitro assays","pmids":["20463172"],"is_preprint":false},{"year":2010,"finding":"PP1 dephosphorylates both SPAK and the N-terminal tail of NKCC1 directly; the PP1 binding motif on NKCC1 facilitates scaffolding of PP1 near SPAK, greatly enhancing PP1-mediated dephosphorylation of SPAK.","method":"In vitro dephosphorylation assay with recombinant proteins, 86Rb+ uptake in Xenopus oocytes, mutagenesis","journal":"The Journal of biological chemistry","confidence":"Medium","confidence_rationale":"Tier 1 — in vitro reconstitution with recombinant proteins plus functional oocyte assay, single lab","pmids":["20223824"],"is_preprint":false},{"year":2010,"finding":"SORLA intracellular sorting receptor functionally interacts with SPAK and controls SPAK intracellular trafficking; SORLA deficiency results in missorting of SPAK and consequent failure to phosphorylate NKCC2 in the thick ascending limb.","method":"Co-immunoprecipitation, SORLA knockout mouse model, phospho-specific Western blot, immunofluorescence","journal":"Molecular and cellular biology","confidence":"Medium","confidence_rationale":"Tier 2 — binding and knockout model with defined molecular phenotype, single lab","pmids":["20385770"],"is_preprint":false},{"year":2011,"finding":"MO25α/β bind SPAK/OSR1 and induce ~100-fold activation of their kinase activity, dramatically enhancing phosphorylation of ion cotransporters NKCC1, NKCC2, and NCC; siRNA-mediated MO25 reduction inhibits endogenous NKCC1 phosphorylation at SPAK/OSR1 sites.","method":"In vitro kinase assay, siRNA knockdown, phospho-specific Western blot, surface plasmon resonance","journal":"The EMBO journal","confidence":"High","confidence_rationale":"Tier 1-2 — large activation magnitude in vitro, confirmed in cells with RNAi rescue; multiple orthogonal methods","pmids":["21423148"],"is_preprint":false},{"year":2011,"finding":"WNK kinases act as scaffolds to recruit SPAK, which phosphorylates CFTR and NBCe1-B to reduce their cell surface expression in pancreatic ductal epithelium; IRBIT opposes WNK/SPAK effects by recruiting PP1 to dephosphorylate CFTR and NBCe1-B; silencing SPAK increases ductal secretion.","method":"siRNA knockdown in mouse pancreatic ducts, cell surface biotinylation, phosphorylation assay, rescue experiments","journal":"The Journal of clinical investigation","confidence":"High","confidence_rationale":"Tier 2 — multiple orthogonal methods with epistasis rescue in intact tissue, single lab","pmids":["21317537"],"is_preprint":false},{"year":2011,"finding":"A kidney-specific truncated SPAK isoform lacking the kinase domain inhibits full-length SPAK-mediated phosphorylation of NCC and NKCC2 in vitro; SPAK knockout has divergent effects along TAL (increased pNKCC2) and DCT (decreased pNCC), explained by differential isoform expression along the nephron.","method":"In vitro kinase assay, SPAK knockout mouse model, isoform-specific Western blot and immunofluorescence","journal":"Cell metabolism","confidence":"High","confidence_rationale":"Tier 1-2 — in vitro isoform inhibition combined with clean knockout phenotyping, validated across multiple labs","pmids":["21907141"],"is_preprint":false},{"year":2012,"finding":"SPAK and OSR1 directly phosphorylate all KCC isoforms at a conserved C-terminal threonine (Site-2, Thr1048 in KCC3A) to promote their inhibition; WNK pathway inhibition suppresses this phosphorylation; cells lacking SPAK/OSR1 activity have elevated KCC3A activity; a Site-2 alanine KCC3A mutant shows increased activity.","method":"In vitro kinase assay with recombinant proteins, SPAK/OSR1 double-knockin ES cells, 86Rb+ uptake, WNK pathway inhibitor","journal":"The Biochemical journal","confidence":"High","confidence_rationale":"Tier 1 — reconstituted in vitro, confirmed in genetic cell model with multiple readouts","pmids":["24393035"],"is_preprint":false},{"year":2012,"finding":"SPAK/OSR1 double-knockin ES cells (where SPAK/OSR1 cannot be activated by WNK) show abolished NKCC1 phosphorylation and activation, providing genetic evidence that NKCC1 is strictly dependent on SPAK/OSR1 activity; WNK1 and WNK3 activity is markedly elevated in knockin cells, revealing a feedback where downstream SPAK/OSR1 influence upstream WNK activity.","method":"Double-knockin ES cell model, 86Rb+ uptake, phospho-specific Western blot","journal":"The Biochemical journal","confidence":"High","confidence_rationale":"Tier 2 — genetic epistasis in ES cells with multiple readouts, single lab but rigorous design","pmids":["22032326"],"is_preprint":false},{"year":2012,"finding":"In the DCT, OSR1 is dependent on SPAK for apical membrane localization and activity; in SPAK knockout mice, OSR1 becomes largely inactive and redistributes from the apical membrane to cytoplasmic WNK1-containing puncta, causing loss of NCC phosphorylation specifically in DCT1.","method":"SPAK knockout mouse model, immunofluorescence, phospho-specific Western blot, subcellular fractionation","journal":"The Journal of biological chemistry","confidence":"High","confidence_rationale":"Tier 2 — clean knockout with defined localization and phosphorylation phenotype","pmids":["22977235"],"is_preprint":false},{"year":2012,"finding":"PI3K/Akt signaling activates the WNK-OSR1/SPAK-NCC phosphorylation cascade in hyperinsulinemic db/db mice; this is evidenced by PI3K inhibitors correcting increased OSR1/SPAK and NCC phosphorylation, and by genetic knockin mice (SpakT243A/+ and Osr1T185A/+) completely correcting increased NCC phosphorylation and elevated blood pressure in db/db mice.","method":"Knockin mouse genetics, pharmacological PI3K/Akt inhibition, phospho-specific Western blot","journal":"Hypertension","confidence":"High","confidence_rationale":"Tier 2 — genetic epistasis with knockin plus pharmacological inhibition, cross-validated","pmids":["22949526"],"is_preprint":false},{"year":2012,"finding":"ASK3 interacts with WNK1 and suppresses the WNK1-SPAK/OSR1 signaling pathway; Ask3 knockout mice display hyperactivation of SPAK/OSR1 in renal tubules and hypertension.","method":"Co-immunoprecipitation, siRNA knockdown, Ask3 knockout mouse model, phospho-specific Western blot, blood pressure measurement","journal":"Nature communications","confidence":"Medium","confidence_rationale":"Tier 2 — genetic knockout with pathway activation readout plus biochemical interaction, single lab","pmids":["23250415"],"is_preprint":false},{"year":2013,"finding":"SPAK phosphorylates NBCe1-B at Ser65 and IRBIT/PP1 at Thr49 to regulate the Na+-HCO3- cotransporter; IRBIT and PIP2 activate NBCe1-B by a convergent non-additive mechanism, with SPAK phosphorylation setting the inhibitory resting state.","method":"In vitro phosphorylation, mutagenesis, functional transport assay in Xenopus oocytes","journal":"Proceedings of the National Academy of Sciences of the United States of America","confidence":"Medium","confidence_rationale":"Tier 1-2 — direct phosphorylation site identification with functional mutagenesis, single lab","pmids":["23431199"],"is_preprint":false},{"year":2013,"finding":"Aldosterone acutely stimulates SPAK phosphorylation in the distal convoluted tubule, which increases NCC phosphorylation and activity without changing total NCC abundance; gene silencing of SPAK eliminates the aldosterone effect on NCC activity; the effect is also SGK1-dependent.","method":"siRNA knockdown of SPAK in mpkDCT cells, phospho-specific Western blot, 22Na+ uptake assay, adrenalectomized rodent model","journal":"American journal of physiology. Renal physiology","confidence":"Medium","confidence_rationale":"Tier 2 — genetic knockdown with functional transport assay in cells and in vivo confirmation, single lab","pmids":["23739593"],"is_preprint":false},{"year":2014,"finding":"WNK4 in association with the scaffold protein Cab39 can activate NKCC1 in a SPAK/OSR1-independent manner; WNK4 possesses a PF2-like domain homologous to the SPAK/OSR1 CCT domain that mediates direct interaction with NKCC1, allowing WNK4 to anchor to the N-terminal domain of NKCC1 and promote cotransporter activation.","method":"Xenopus oocyte expression, yeast two-hybrid, homology modeling, 86Rb+ uptake, mutagenesis","journal":"The Journal of biological chemistry","confidence":"Medium","confidence_rationale":"Tier 2 — multiple binding and functional assays but single lab","pmids":["24811174"],"is_preprint":false},{"year":2015,"finding":"The CCT domain Leu502 residue of SPAK is essential for interaction with RFXV/I motifs in WNK1, NCC, and NKCC2; CCT domain L502A knock-in mice abolish these co-immunoprecipitation interactions, show markedly reduced SPAK kinase activity and NCC/NKCC2 phosphorylation, and display Gitelman syndrome features with reduced blood pressure.","method":"Knock-in mouse genetics, co-immunoprecipitation, phospho-specific Western blot, blood pressure/electrolyte measurement","journal":"Human molecular genetics","confidence":"High","confidence_rationale":"Tier 2 — genetic knock-in with defined docking mutation, multiple readouts, physiological confirmation","pmids":["25994507"],"is_preprint":false},{"year":2015,"finding":"Crystal structures of SPAK kinase domain (SPAK 63-403 at 3.1 Å and T243D mutant at 2.5 Å) reveal domain-swapped dimer conformations; a monomeric SPAK mutant retains kinase activity and is activated by WNK1 but shows reduced phosphorylation of NKCC2, indicating domain swapping modulates substrate access rather than intrinsic catalysis.","method":"X-ray crystallography, site-directed mutagenesis, in vitro kinase assay","journal":"Biochemistry","confidence":"High","confidence_rationale":"Tier 1 — crystal structures combined with mutagenesis and functional kinase assay","pmids":["26208601"],"is_preprint":false},{"year":2017,"finding":"Constitutively active SPAK (kinase-activating mutation in Stk39) expressed specifically in the DCT causes thiazide-treatable hypertension and hyperkalemia with NCC hyperphosphorylation; CA-SPAK drives ASDN remodeling with reduced connecting tubule mass and decreased ENaC and ROMK apical expression, revealing a DCT-ASDN structural coupling mechanism.","method":"Conditional knock-in mouse with DCT-specific Cre, phospho-specific Western blot, immunofluorescence, thiazide challenge","journal":"Journal of the American Society of Nephrology : JASN","confidence":"High","confidence_rationale":"Tier 2 — conditional kinase-activating knockin with defined structural and functional phenotypes","pmids":["28442491"],"is_preprint":false},{"year":2017,"finding":"Allosteric inhibitors (rafoxanide, closantel) bind a conserved pocket on the C-terminal domains of SPAK and OSR1, distinct from the ATP-binding site, and inhibit kinase activity by targeting this allosteric site.","method":"In silico screening, in vitro kinase assay, binding studies","journal":"ChemMedChem","confidence":"Medium","confidence_rationale":"Tier 3 — allosteric site identification by in silico and in vitro assay, single lab","pmids":["28371477"],"is_preprint":false},{"year":2019,"finding":"WNK4 is the primary active WNK isoform in WNK bodies (spherical cytoplasmic condensates in DCT) and catalyzes SPAK/OSR1 phosphorylation therein; phosphorylated SPAK/OSR1 is present both at the apical membrane and in WNK bodies during K+ deprivation; WNK body formation requires Kir4.1-dependent K+ sensing in the DCT.","method":"Immunofluorescence in WNK4-deficient and Kir4.1-conditional KO mice, phospho-specific antibodies, dietary manipulation","journal":"American journal of physiology. Renal physiology","confidence":"Medium","confidence_rationale":"Tier 2 — genetic mouse models with localization and phosphorylation readouts, single lab","pmids":["31736353"],"is_preprint":false},{"year":2020,"finding":"The SPAK inhibitor ZT-1a (5-chloro-N-(5-chloro-4-((4-chlorophenyl)(cyano)methyl)-2-methylphenyl)-2-hydroxybenzamide) decreases SPAK-dependent phosphorylation of NKCC1 and simultaneously stimulates KCCs by reducing their SPAK-dependent phosphorylation; intracerebroventricular ZT-1a reduces CSF hypersecretion in post-hemorrhagic hydrocephalus; systemic ZT-1a reduces ischemia-induced CCC phosphorylation and cerebral edema in stroke.","method":"In vitro kinase assay, rodent stroke/hydrocephalus models, CCC phosphorylation assay, pharmacological inhibition","journal":"Nature communications","confidence":"High","confidence_rationale":"Tier 1-2 — in vitro target engagement plus multiple in vivo disease models with defined molecular readouts","pmids":["31911626"],"is_preprint":false},{"year":2021,"finding":"STK39 interacts with and phosphorylates SNAI1 at T203, promoting SNAI1 nuclear retention and stability in breast cancer cells; STK39 inhibition destabilizes SNAI1, impairs EMT, and reduces tumor cell migration, invasion, and metastasis in vitro and in vivo.","method":"Co-immunoprecipitation, in vitro kinase/phosphorylation assay, subcellular fractionation, knockdown/overexpression functional assays, xenograft model","journal":"Theranostics","confidence":"Medium","confidence_rationale":"Tier 2 — direct phosphorylation site identified with multiple functional readouts, single lab","pmids":["34335956"],"is_preprint":false},{"year":2021,"finding":"STK39 binds PLK1 (identified by mass spectrometry) and promotes HCC progression by activating the ERK signaling pathway in a PLK1-dependent manner; STK39 knockdown arrests cells in G2/M and promotes apoptosis.","method":"Mass spectrometry, co-immunoprecipitation, RNA-seq, siRNA knockdown, cell cycle and apoptosis assays","journal":"Theranostics","confidence":"Medium","confidence_rationale":"Tier 2-3 — MS-identified interaction with functional validation, single lab","pmids":["33500714"],"is_preprint":false}],"current_model":"STK39/SPAK is a STE20-family serine/threonine kinase that is activated by WNK kinases (via phosphorylation of its T-loop Thr243 and regulatory Ser383) and by the scaffold MO25, and that in turn directly phosphorylates and stimulates Na+-driven cation-chloride cotransporters (NKCC1, NKCC2, NCC) while simultaneously phosphorylating and inhibiting K+-driven KCC family members at conserved C-terminal threonine residues; substrate recognition and upstream activation both depend on a conserved C-terminal CCT domain that docks RFXV/I motifs on WNKs and cotransporters, and this WNK-SPAK axis is the primary in vivo regulator of renal salt reabsorption, vascular tone, and neuronal Cl- homeostasis, with additional roles in T-cell AP-1 signaling (via PKCθ), epithelial HCO3- secretion (via CFTR/NBCe1-B phosphorylation), and cancer cell invasion (via SNAI1 phosphorylation at T203)."},"narrative":{"teleology":[{"year":2000,"claim":"Establishing that SPAK is an active kinase capable of autophosphorylation and exogenous substrate phosphorylation resolved the basic question of whether STK39 encodes a functional kinase, and its activation of p38 MAPK placed it in a stress-signaling context.","evidence":"In vitro kinase assay and cotransfection reporter assays in mammalian cells","pmids":["10980603"],"confidence":"Medium","gaps":["Physiological substrates unidentified","p38 activation mechanism unclear (direct vs. indirect)","Upstream activator unknown"]},{"year":2002,"claim":"Discovery that SPAK directly binds cation-chloride cotransporters NKCC1, NKCC2, and KCC3 via a C-terminal domain recognizing RFXV/I motifs identified the first physiological substrate class and the docking mechanism, fundamentally redirecting the field from stress-kinase signaling to ion transport regulation.","evidence":"Yeast two-hybrid, GST pulldown, co-immunoprecipitation from mouse brain","pmids":["12386165"],"confidence":"High","gaps":["Whether SPAK phosphorylates these cotransporters was not yet shown","Identity of upstream activating kinase unknown"]},{"year":2004,"claim":"Identification of PKCθ as an upstream kinase phosphorylating SPAK at S311 and the demonstration that SPAK activates AP-1 in T cells established a non-ion-transport signaling role and the first upstream phosphorylation event on SPAK.","evidence":"Co-immunoprecipitation, in vitro kinase assay, RNAi, reporter assay in T cells","pmids":["14988727"],"confidence":"High","gaps":["Whether this PKCθ-SPAK axis operates on cotransporters unknown","Relationship to WNK signaling unclear"]},{"year":2005,"claim":"The pivotal discovery that WNK1 phosphorylates SPAK and that SPAK/OSR1 in turn directly phosphorylate the N-terminal regulatory regions of NKCC1, NKCC2, and NCC established the WNK→SPAK→CCC phosphorylation cascade as a coherent signaling pathway governing cation-chloride cotransport.","evidence":"In vitro kinase assay with site-directed mutagenesis, cell-based phosphorylation assays","pmids":["16263722"],"confidence":"High","gaps":["Specific phosphosites on cotransporters not yet mapped","In vivo relevance unconfirmed"]},{"year":2006,"claim":"Detailed characterization of the CCT domain's nanomolar-affinity RFXV-motif binding, identification of activation-loop residues T243/T247 as essential for catalysis, and mapping of NKCC1 phosphorylation sites (T203/T207/T212) provided the structural and biochemical framework for SPAK substrate recognition and activation.","evidence":"Surface plasmon resonance, X-ray-guided mutagenesis, 86Rb⁺ uptake in Xenopus oocytes, in vitro kinase assays","pmids":["16669787","16382158"],"confidence":"High","gaps":["Full crystal structure of CCT-RFXV complex not yet solved","Regulation of SPAK by scaffolds other than WNK unknown"]},{"year":2008,"claim":"Extension of the WNK-SPAK cascade to NCC (mapping phosphosites T46/T55/T60) and demonstration that PKCδ also activates SPAK during osmotic stress broadened the upstream inputs and downstream substrates of the pathway beyond NKCC1.","evidence":"In vitro kinase assay with phospho-specific antibodies in kidney cells; siRNA and 86Rb⁺ flux in airway epithelia","pmids":["18270262","18550547"],"confidence":"High","gaps":["In vivo significance of PKCδ-SPAK axis unconfirmed","Relative contributions of SPAK vs. OSR1 to NCC regulation unknown"]},{"year":2010,"claim":"SPAK knockout and WNK-binding-deficient knock-in mice provided definitive in vivo proof that SPAK is the essential kinase for NCC phosphorylation, regulates NKCC1-dependent vascular tone, and controls blood pressure, producing a Gitelman-like phenotype with hypotension.","evidence":"SPAK-null and knock-in mouse models with phospho-Western, blood pressure, and vascular contractility assays","pmids":["20813865","20091762"],"confidence":"High","gaps":["Compensatory OSR1 effects not fully dissected","Tissue-specific isoform contributions unclear"]},{"year":2011,"claim":"Discovery that MO25 activates SPAK ~100-fold and that a kidney-specific truncated SPAK isoform acts as a dominant-negative inhibitor explained how SPAK activity is fine-tuned and why SPAK knockout has divergent effects on NCC vs. NKCC2 phosphorylation along the nephron.","evidence":"In vitro kinase assay with MO25, siRNA, SPAK knockout mouse with isoform-specific analysis","pmids":["21423148","21907141"],"confidence":"High","gaps":["How MO25 binding is regulated in vivo unknown","Whether truncated isoform has independent functions unclear"]},{"year":2012,"claim":"Demonstration that SPAK/OSR1 phosphorylate KCC family members at a conserved C-terminal threonine to inhibit them established that SPAK reciprocally regulates Na⁺-importing (NKCC/NCC activated) and K⁺-exporting (KCC inhibited) cotransporters, unifying chloride homeostasis under one kinase.","evidence":"In vitro kinase assay, SPAK/OSR1 double-knockin ES cells, 86Rb⁺ uptake","pmids":["24393035"],"confidence":"High","gaps":["In vivo KCC phosphorylation by SPAK not yet confirmed in genetic models","Contribution to neuronal Cl⁻ homeostasis inferred but not directly tested"]},{"year":2012,"claim":"Genetic epistasis in PI3K/Akt-hyperactive db/db mice showed that insulin signaling activates the WNK-SPAK-NCC cascade, and SPAK-inactivating knock-in completely rescued hypertension, linking metabolic syndrome to SPAK-dependent salt retention.","evidence":"SpakT243A/+ knock-in crossed with db/db mice, PI3K inhibitor, phospho-Western","pmids":["22949526"],"confidence":"High","gaps":["Direct phosphorylation link between Akt and WNK not established","Translation to human metabolic hypertension unconfirmed"]},{"year":2015,"claim":"Crystal structures of the SPAK kinase domain revealed domain-swapped dimers that modulate substrate access rather than intrinsic catalysis, and CCT domain L502A knock-in mice confirmed that a single docking residue is essential for all RFXV-dependent interactions in vivo.","evidence":"X-ray crystallography at 2.5–3.1 Å resolution; L502A knock-in mice with Co-IP, phospho-Western, blood pressure","pmids":["26208601","25994507"],"confidence":"High","gaps":["Full-length SPAK structure not available","Whether dimerization occurs in cells undemonstrated"]},{"year":2017,"claim":"DCT-specific constitutively active SPAK knock-in mice developed thiazide-sensitive hypertension with hyperkalemia and ASDN remodeling, proving that SPAK activation in a single nephron segment is sufficient to drive systemic blood pressure elevation and revealing DCT-ASDN structural coupling.","evidence":"Conditional CA-SPAK knock-in with DCT-specific Cre, immunofluorescence, thiazide challenge","pmids":["28442491"],"confidence":"High","gaps":["Molecular signals mediating ASDN remodeling downstream of SPAK unknown","Whether CA-SPAK also alters KCC phosphorylation in vivo not tested"]},{"year":2020,"claim":"The SPAK inhibitor ZT-1a demonstrated that pharmacological SPAK inhibition simultaneously reduces NKCC1 phosphorylation and relieves KCC inhibition in vivo, attenuating cerebral edema and CSF hypersecretion, validating SPAK as a druggable target for neurological fluid disorders.","evidence":"In vitro kinase assay, rodent stroke and hydrocephalus models with CCC phosphorylation readouts","pmids":["31911626"],"confidence":"High","gaps":["Off-target effects of ZT-1a not fully profiled","Long-term safety and specificity in vivo unknown"]},{"year":2021,"claim":"Identification of SNAI1 as a SPAK substrate phosphorylated at T203, promoting SNAI1 nuclear retention and EMT in breast cancer, extended SPAK's substrate repertoire beyond ion transport to transcription factor regulation and cancer metastasis.","evidence":"Co-immunoprecipitation, in vitro kinase assay, knockdown/overexpression, xenograft model","pmids":["34335956"],"confidence":"Medium","gaps":["Whether SNAI1 phosphorylation depends on the CCT-RFXV docking mechanism is untested","Relevance to other cancer types unknown","Independent replication needed"]},{"year":null,"claim":"Key unresolved questions include the full-length SPAK structure with CCT domain and MO25, the molecular basis of SPAK dimerization in cells, the relative tissue-specific contributions of SPAK vs. OSR1, the mechanism by which SPAK regulates cell cycle and apoptosis independently of ion transport, and whether SPAK inhibitors can be developed for safe clinical use in hypertension and neurological disorders.","evidence":"","pmids":[],"confidence":"Low","gaps":["No full-length SPAK structure available","SPAK vs. OSR1 tissue-specific redundancy not genetically resolved in all organs","Cancer and cell-cycle roles lack mechanistic depth"]}],"mechanism_profile":{"molecular_activity":[{"term_id":"GO:0140096","term_label":"catalytic activity, acting on a protein","supporting_discovery_ids":[0,4,5,6,8,10,17,20,23,37]},{"term_id":"GO:0098772","term_label":"molecular function regulator activity","supporting_discovery_ids":[22,23]}],"localization":[{"term_id":"GO:0005829","term_label":"cytosol","supporting_discovery_ids":[0,35]},{"term_id":"GO:0005634","term_label":"nucleus","supporting_discovery_ids":[0]},{"term_id":"GO:0005886","term_label":"plasma membrane","supporting_discovery_ids":[25,35]}],"pathway":[{"term_id":"R-HSA-382551","term_label":"Transport of small molecules","supporting_discovery_ids":[1,4,8,10,15,16,23,36]},{"term_id":"R-HSA-162582","term_label":"Signal Transduction","supporting_discovery_ids":[3,13,26,27]},{"term_id":"R-HSA-168256","term_label":"Immune System","supporting_discovery_ids":[3]},{"term_id":"R-HSA-1643685","term_label":"Disease","supporting_discovery_ids":[37,38]}],"complexes":[],"partners":["WNK1","WNK4","OXSR1","SLC12A2","SLC12A3","SLC12A1","CAB39","PRKCQ"],"other_free_text":[]},"mechanistic_narrative":"STK39 (SPAK) is a STE20-family serine/threonine kinase that functions as the central effector of the WNK signaling cascade to regulate ion homeostasis in kidney, vasculature, and brain. WNK kinases phosphorylate SPAK at T-loop residue T243 and regulatory S383, and the scaffold MO25 further amplifies SPAK activity ~100-fold; activated SPAK then directly phosphorylates N-terminal threonines on Na⁺-coupled cation-chloride cotransporters NKCC1, NKCC2, and NCC to stimulate their activity, while simultaneously phosphorylating a conserved C-terminal threonine on KCC family members to inhibit them [PMID:16263722, PMID:21423148, PMID:24393035]. Substrate recognition and upstream docking both require the conserved C-terminal CCT domain, which binds RFXV/I motifs on WNKs and cotransporters with nanomolar affinity [PMID:16669787, PMID:25994507]. SPAK knockout or WNK-binding-deficient knock-in mice develop a Gitelman-like syndrome with reduced blood pressure, establishing SPAK as the primary in vivo regulator of renal salt reabsorption and vascular tone, with additional roles in epithelial HCO₃⁻ secretion via CFTR/NBCe1-B phosphorylation, T-cell AP-1 signaling via PKCθ, and cancer cell invasion via SNAI1 phosphorylation [PMID:20813865, PMID:20091762, PMID:21317537, PMID:14988727, PMID:34335956]."},"prefetch_data":{"uniprot":{"accession":"Q9UEW8","full_name":"STE20/SPS1-related proline-alanine-rich protein kinase","aliases":["DCHT","Serine/threonine-protein kinase 39"],"length_aa":545,"mass_kda":59.5,"function":"Effector serine/threonine-protein kinase component of the WNK-SPAK/OSR1 kinase cascade, which is involved in various processes, such as ion transport, response to hypertonic stress and blood pressure (PubMed:16669787, PubMed:18270262, PubMed:21321328, PubMed:34289367). Specifically recognizes and binds proteins with a RFXV motif (PubMed:16669787, PubMed:21321328). Acts downstream of WNK kinases (WNK1, WNK2, WNK3 or WNK4): following activation by WNK kinases, catalyzes phosphorylation of ion cotransporters, such as SLC12A1/NKCC2, SLC12A2/NKCC1, SLC12A3/NCC, SLC12A5/KCC2 or SLC12A6/KCC3, regulating their activity (PubMed:21321328). Mediates regulatory volume increase in response to hyperosmotic stress by catalyzing phosphorylation of ion cotransporters SLC12A1/NKCC2, SLC12A2/NKCC1 and SLC12A6/KCC3 downstream of WNK1 and WNK3 kinases (PubMed:12740379, PubMed:16669787, PubMed:21321328). Phosphorylation of Na-K-Cl cotransporters SLC12A2/NKCC1 and SLC12A2/NKCC1 promote their activation and ion influx; simultaneously, phosphorylation of K-Cl cotransporters SLC12A5/KCC2 and SLC12A6/KCC3 inhibit their activity, blocking ion efflux (PubMed:16669787, PubMed:19665974, PubMed:21321328). Acts as a regulator of NaCl reabsorption in the distal nephron by mediating phosphorylation and activation of the thiazide-sensitive Na-Cl cotransporter SLC12A3/NCC in distal convoluted tubule cells of kidney downstream of WNK4 (PubMed:18270262). Mediates the inhibition of SLC4A4, SLC26A6 as well as CFTR activities (By similarity). Phosphorylates RELT (By similarity)","subcellular_location":"Cytoplasm; Nucleus","url":"https://www.uniprot.org/uniprotkb/Q9UEW8/entry"},"depmap":{"release":"DepMap","has_data":true,"is_common_essential":false,"resolved_as":"","url":"https://depmap.org/portal/gene/STK39","classification":"Not Classified","n_dependent_lines":8,"n_total_lines":1208,"dependency_fraction":0.006622516556291391},"opencell":{"profiled":false,"resolved_as":"","ensg_id":"","cell_line_id":"","localizations":[],"interactors":[],"url":"https://opencell.sf.czbiohub.org/search/STK39","total_profiled":1310},"omim":[{"mim_id":"614495","title":"PSEUDOHYPOALDOSTERONISM, TYPE IID; PHA2D","url":"https://www.omim.org/entry/614495"},{"mim_id":"607648","title":"SERINE/THREONINE PROTEIN KINASE 39; STK39","url":"https://www.omim.org/entry/607648"},{"mim_id":"606249","title":"PROTEIN KINASE, LYSINE-DEFICIENT 2; WNK2","url":"https://www.omim.org/entry/606249"},{"mim_id":"605775","title":"KELCH-LIKE 3; KLHL3","url":"https://www.omim.org/entry/605775"},{"mim_id":"604046","title":"OXIDATIVE STRESS-RESPONSIVE 1; OXSR1","url":"https://www.omim.org/entry/604046"}],"hpa":{"profiled":true,"resolved_as":"","reliability":"Supported","locations":[{"location":"Nucleoplasm","reliability":"Supported"},{"location":"Vesicles","reliability":"Additional"},{"location":"Cytosol","reliability":"Additional"}],"tissue_specificity":"Low tissue specificity","tissue_distribution":"Detected in all","driving_tissues":[],"url":"https://www.proteinatlas.org/search/STK39"},"hgnc":{"alias_symbol":["DCHT","SPAK"],"prev_symbol":[]},"alphafold":{"accession":"Q9UEW8","domains":[{"cath_id":"3.30.200.20","chopping":"61-138","consensus_level":"medium","plddt":85.4486,"start":61,"end":138},{"cath_id":"1.10.510.10","chopping":"142-222_230-362","consensus_level":"high","plddt":87.1351,"start":142,"end":362},{"cath_id":"3.10.20.90","chopping":"453-545","consensus_level":"high","plddt":86.4892,"start":453,"end":545}],"viewer_url":"https://alphafold.ebi.ac.uk/entry/Q9UEW8","model_url":"https://alphafold.ebi.ac.uk/files/AF-Q9UEW8-F1-model_v6.cif","pae_url":"https://alphafold.ebi.ac.uk/files/AF-Q9UEW8-F1-predicted_aligned_error_v6.png","plddt_mean":75.06},"mouse_models":{"mgi_url":"https://www.informatics.jax.org/marker/summary?nomen=STK39","jax_strain_url":"https://www.jax.org/strain/search?query=STK39"},"sequence":{"accession":"Q9UEW8","fasta_url":"https://rest.uniprot.org/uniprotkb/Q9UEW8.fasta","uniprot_url":"https://www.uniprot.org/uniprotkb/Q9UEW8/entry","alphafold_viewer_url":"https://alphafold.ebi.ac.uk/entry/Q9UEW8"}},"corpus_meta":[{"pmid":"16263722","id":"PMC_16263722","title":"WNK1 regulates phosphorylation of cation-chloride-coupled cotransporters via the STE20-related kinases, SPAK and OSR1.","date":"2005","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/16263722","citation_count":388,"is_preprint":false},{"pmid":"12386165","id":"PMC_12386165","title":"Cation chloride cotransporters interact with the stress-related kinases Ste20-related proline-alanine-rich kinase (SPAK) and oxidative stress response 1 (OSR1).","date":"2002","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/12386165","citation_count":318,"is_preprint":false},{"pmid":"18270262","id":"PMC_18270262","title":"Activation of the thiazide-sensitive Na+-Cl- cotransporter by the WNK-regulated kinases SPAK and OSR1.","date":"2008","source":"Journal of cell science","url":"https://pubmed.ncbi.nlm.nih.gov/18270262","citation_count":317,"is_preprint":false},{"pmid":"16669787","id":"PMC_16669787","title":"Functional interactions of the SPAK/OSR1 kinases with their upstream activator WNK1 and downstream substrate NKCC1.","date":"2006","source":"The Biochemical journal","url":"https://pubmed.ncbi.nlm.nih.gov/16669787","citation_count":261,"is_preprint":false},{"pmid":"18843116","id":"PMC_18843116","title":"The regulation of salt transport and blood pressure by the WNK-SPAK/OSR1 signalling pathway.","date":"2008","source":"Journal of cell science","url":"https://pubmed.ncbi.nlm.nih.gov/18843116","citation_count":249,"is_preprint":false},{"pmid":"20813865","id":"PMC_20813865","title":"SPAK-knockout mice manifest Gitelman syndrome and impaired vasoconstriction.","date":"2010","source":"Journal of the American Society of Nephrology : JASN","url":"https://pubmed.ncbi.nlm.nih.gov/20813865","citation_count":239,"is_preprint":false},{"pmid":"19114657","id":"PMC_19114657","title":"From the Cover: Whole-genome association study identifies STK39 as a hypertension susceptibility gene.","date":"2008","source":"Proceedings of the National Academy of Sciences of the United States of America","url":"https://pubmed.ncbi.nlm.nih.gov/19114657","citation_count":236,"is_preprint":false},{"pmid":"20091762","id":"PMC_20091762","title":"Role of the WNK-activated SPAK kinase in regulating blood pressure.","date":"2010","source":"EMBO molecular medicine","url":"https://pubmed.ncbi.nlm.nih.gov/20091762","citation_count":227,"is_preprint":false},{"pmid":"25028718","id":"PMC_25028718","title":"The WNK-SPAK/OSR1 pathway: master regulator of cation-chloride cotransporters.","date":"2014","source":"Science signaling","url":"https://pubmed.ncbi.nlm.nih.gov/25028718","citation_count":212,"is_preprint":false},{"pmid":"19240212","id":"PMC_19240212","title":"Angiotensin II signaling increases activity of the renal Na-Cl cotransporter through a WNK4-SPAK-dependent pathway.","date":"2009","source":"Proceedings of the National Academy of Sciences of the United States of America","url":"https://pubmed.ncbi.nlm.nih.gov/19240212","citation_count":201,"is_preprint":false},{"pmid":"18550832","id":"PMC_18550832","title":"Regulation of NKCC2 by a chloride-sensing mechanism involving the WNK3 and SPAK kinases.","date":"2008","source":"Proceedings of the National Academy of Sciences of the United States of America","url":"https://pubmed.ncbi.nlm.nih.gov/18550832","citation_count":194,"is_preprint":false},{"pmid":"21907141","id":"PMC_21907141","title":"A SPAK isoform switch modulates renal salt transport and blood pressure.","date":"2011","source":"Cell metabolism","url":"https://pubmed.ncbi.nlm.nih.gov/21907141","citation_count":181,"is_preprint":false},{"pmid":"24393035","id":"PMC_24393035","title":"The WNK-regulated SPAK/OSR1 kinases directly phosphorylate and inhibit the K+-Cl- co-transporters.","date":"2014","source":"The Biochemical journal","url":"https://pubmed.ncbi.nlm.nih.gov/24393035","citation_count":175,"is_preprint":false},{"pmid":"14563843","id":"PMC_14563843","title":"Characterization of the interaction of the stress kinase SPAK with the Na+-K+-2Cl- cotransporter in the nervous system: evidence for a scaffolding role of the kinase.","date":"2003","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/14563843","citation_count":175,"is_preprint":false},{"pmid":"18800028","id":"PMC_18800028","title":"Dietary salt regulates the phosphorylation of OSR1/SPAK kinases and the sodium chloride cotransporter through aldosterone.","date":"2008","source":"Kidney international","url":"https://pubmed.ncbi.nlm.nih.gov/18800028","citation_count":169,"is_preprint":false},{"pmid":"18092945","id":"PMC_18092945","title":"SPAK and OSR1: STE20 kinases involved in the regulation of ion homoeostasis and volume control in mammalian cells.","date":"2008","source":"The Biochemical journal","url":"https://pubmed.ncbi.nlm.nih.gov/18092945","citation_count":163,"is_preprint":false},{"pmid":"21321328","id":"PMC_21321328","title":"Regulation of the NKCC2 ion cotransporter by SPAK-OSR1-dependent and -independent pathways.","date":"2011","source":"Journal of cell science","url":"https://pubmed.ncbi.nlm.nih.gov/21321328","citation_count":161,"is_preprint":false},{"pmid":"16382158","id":"PMC_16382158","title":"Characterization of SPAK and OSR1, regulatory kinases of the Na-K-2Cl cotransporter.","date":"2006","source":"Molecular and cellular biology","url":"https://pubmed.ncbi.nlm.nih.gov/16382158","citation_count":136,"is_preprint":false},{"pmid":"10980603","id":"PMC_10980603","title":"SPAK, a STE20/SPS1-related kinase that activates the p38 pathway.","date":"2000","source":"Oncogene","url":"https://pubmed.ncbi.nlm.nih.gov/10980603","citation_count":122,"is_preprint":false},{"pmid":"21423148","id":"PMC_21423148","title":"MO25 is a master regulator of SPAK/OSR1 and MST3/MST4/YSK1 protein kinases.","date":"2011","source":"The EMBO journal","url":"https://pubmed.ncbi.nlm.nih.gov/21423148","citation_count":121,"is_preprint":false},{"pmid":"28442491","id":"PMC_28442491","title":"Constitutively Active SPAK Causes Hyperkalemia by Activating NCC and Remodeling Distal Tubules.","date":"2017","source":"Journal of the American Society of Nephrology : JASN","url":"https://pubmed.ncbi.nlm.nih.gov/28442491","citation_count":118,"is_preprint":false},{"pmid":"22977235","id":"PMC_22977235","title":"SPAK isoforms and OSR1 regulate sodium-chloride co-transporters in a nephron-specific manner.","date":"2012","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/22977235","citation_count":118,"is_preprint":false},{"pmid":"23073627","id":"PMC_23073627","title":"Molecular physiology of SPAK and OSR1: two Ste20-related protein kinases regulating ion transport.","date":"2012","source":"Physiological reviews","url":"https://pubmed.ncbi.nlm.nih.gov/23073627","citation_count":115,"is_preprint":false},{"pmid":"22032326","id":"PMC_22032326","title":"SPAK/OSR1 regulate NKCC1 and WNK activity: analysis of WNK isoform interactions and activation by T-loop trans-autophosphorylation.","date":"2012","source":"The Biochemical journal","url":"https://pubmed.ncbi.nlm.nih.gov/22032326","citation_count":114,"is_preprint":false},{"pmid":"31911626","id":"PMC_31911626","title":"Modulation of brain cation-Cl- cotransport via the SPAK kinase inhibitor ZT-1a.","date":"2020","source":"Nature communications","url":"https://pubmed.ncbi.nlm.nih.gov/31911626","citation_count":88,"is_preprint":false},{"pmid":"22949526","id":"PMC_22949526","title":"Phosphatidylinositol 3-kinase/Akt signaling pathway activates the WNK-OSR1/SPAK-NCC phosphorylation cascade in hyperinsulinemic db/db mice.","date":"2012","source":"Hypertension (Dallas, Tex. : 1979)","url":"https://pubmed.ncbi.nlm.nih.gov/22949526","citation_count":87,"is_preprint":false},{"pmid":"23393317","id":"PMC_23393317","title":"SPAK differentially mediates vasopressin effects on sodium cotransporters.","date":"2013","source":"Journal of the American Society of Nephrology : JASN","url":"https://pubmed.ncbi.nlm.nih.gov/23393317","citation_count":87,"is_preprint":false},{"pmid":"21317537","id":"PMC_21317537","title":"IRBIT governs epithelial secretion in mice by antagonizing the WNK/SPAK kinase pathway.","date":"2011","source":"The Journal of clinical investigation","url":"https://pubmed.ncbi.nlm.nih.gov/21317537","citation_count":86,"is_preprint":false},{"pmid":"15767308","id":"PMC_15767308","title":"Hypotonic shock mediation by p38 MAPK, JNK, PKC, FAK, OSR1 and SPAK in osmosensing chloride secreting cells of killifish opercular epithelium.","date":"2005","source":"The Journal of experimental biology","url":"https://pubmed.ncbi.nlm.nih.gov/15767308","citation_count":85,"is_preprint":false},{"pmid":"25113964","id":"PMC_25113964","title":"WNK-SPAK-NCC cascade revisited: WNK1 stimulates the activity of the Na-Cl cotransporter via SPAK, an effect antagonized by WNK4.","date":"2014","source":"Hypertension (Dallas, Tex. : 1979)","url":"https://pubmed.ncbi.nlm.nih.gov/25113964","citation_count":81,"is_preprint":false},{"pmid":"22549242","id":"PMC_22549242","title":"Aldosterone does not require angiotensin II to activate NCC through a WNK4-SPAK-dependent pathway.","date":"2012","source":"Pflugers Archiv : European journal of physiology","url":"https://pubmed.ncbi.nlm.nih.gov/22549242","citation_count":76,"is_preprint":false},{"pmid":"14988727","id":"PMC_14988727","title":"SPAK kinase is a substrate and target of PKCtheta in T-cell receptor-induced AP-1 activation pathway.","date":"2004","source":"The EMBO journal","url":"https://pubmed.ncbi.nlm.nih.gov/14988727","citation_count":74,"is_preprint":false},{"pmid":"23431199","id":"PMC_23431199","title":"Convergence of IRBIT, phosphatidylinositol (4,5) bisphosphate, and WNK/SPAK kinases in regulation of the Na+-HCO3- cotransporters family.","date":"2013","source":"Proceedings of the National Academy of Sciences of the United States of America","url":"https://pubmed.ncbi.nlm.nih.gov/23431199","citation_count":68,"is_preprint":false},{"pmid":"23250415","id":"PMC_23250415","title":"ASK3 responds to osmotic stress and regulates blood pressure by suppressing WNK1-SPAK/OSR1 signaling in the kidney.","date":"2012","source":"Nature communications","url":"https://pubmed.ncbi.nlm.nih.gov/23250415","citation_count":61,"is_preprint":false},{"pmid":"20175999","id":"PMC_20175999","title":"Effect of angiotensin II on the WNK-OSR1/SPAK-NCC phosphorylation cascade in cultured mpkDCT cells and in vivo mouse kidney.","date":"2010","source":"Biochemical and biophysical research communications","url":"https://pubmed.ncbi.nlm.nih.gov/20175999","citation_count":61,"is_preprint":false},{"pmid":"25362046","id":"PMC_25362046","title":"Actions of the protein kinase WNK1 on endothelial cells are differentially mediated by its substrate kinases OSR1 and SPAK.","date":"2014","source":"Proceedings of the National Academy of Sciences of the United States of America","url":"https://pubmed.ncbi.nlm.nih.gov/25362046","citation_count":61,"is_preprint":false},{"pmid":"25377078","id":"PMC_25377078","title":"Discovery of Novel SPAK Inhibitors That Block WNK Kinase Signaling to Cation Chloride Transporters.","date":"2014","source":"Journal of the American Society of Nephrology : JASN","url":"https://pubmed.ncbi.nlm.nih.gov/25377078","citation_count":60,"is_preprint":false},{"pmid":"21486947","id":"PMC_21486947","title":"Phenotypes of pseudohypoaldosteronism type II caused by the WNK4 D561A missense mutation are dependent on the WNK-OSR1/SPAK kinase cascade.","date":"2011","source":"Journal of cell science","url":"https://pubmed.ncbi.nlm.nih.gov/21486947","citation_count":58,"is_preprint":false},{"pmid":"17595523","id":"PMC_17595523","title":"A single binding motif is required for SPAK activation of the Na-K-2Cl cotransporter.","date":"2007","source":"Cellular physiology and biochemistry : international journal of experimental cellular physiology, biochemistry, and pharmacology","url":"https://pubmed.ncbi.nlm.nih.gov/17595523","citation_count":56,"is_preprint":false},{"pmid":"25651563","id":"PMC_25651563","title":"SPAK-mediated NCC regulation in response to low-K+ diet.","date":"2015","source":"American journal of physiology. Renal physiology","url":"https://pubmed.ncbi.nlm.nih.gov/25651563","citation_count":56,"is_preprint":false},{"pmid":"17032814","id":"PMC_17032814","title":"Genome-wide analysis of SPAK/OSR1 binding motifs.","date":"2006","source":"Physiological genomics","url":"https://pubmed.ncbi.nlm.nih.gov/17032814","citation_count":55,"is_preprint":false},{"pmid":"31736353","id":"PMC_31736353","title":"WNK bodies cluster WNK4 and SPAK/OSR1 to promote NCC activation in hypokalemia.","date":"2019","source":"American journal of physiology. Renal physiology","url":"https://pubmed.ncbi.nlm.nih.gov/31736353","citation_count":53,"is_preprint":false},{"pmid":"27068441","id":"PMC_27068441","title":"SPAK and OSR1 play essential roles in potassium homeostasis through actions on the distal convoluted tubule.","date":"2016","source":"The Journal of physiology","url":"https://pubmed.ncbi.nlm.nih.gov/27068441","citation_count":52,"is_preprint":false},{"pmid":"20463172","id":"PMC_20463172","title":"On the substrate recognition and negative regulation of SPAK, a kinase modulating Na+-K+-2Cl- cotransport activity.","date":"2010","source":"American journal of physiology. Cell physiology","url":"https://pubmed.ncbi.nlm.nih.gov/20463172","citation_count":51,"is_preprint":false},{"pmid":"16734747","id":"PMC_16734747","title":"SPAK and OSR1, key kinases involved in the regulation of chloride transport.","date":"2006","source":"Acta physiologica (Oxford, England)","url":"https://pubmed.ncbi.nlm.nih.gov/16734747","citation_count":51,"is_preprint":false},{"pmid":"17267545","id":"PMC_17267545","title":"Apoptosis-associated tyrosine kinase scaffolding of protein phosphatase 1 and SPAK reveals a novel pathway for Na-K-2C1 cotransporter regulation.","date":"2007","source":"American journal of physiology. Cell physiology","url":"https://pubmed.ncbi.nlm.nih.gov/17267545","citation_count":51,"is_preprint":false},{"pmid":"24019400","id":"PMC_24019400","title":"Dietary salt intake regulates WNK3-SPAK-NKCC1 phosphorylation cascade in mouse aorta through angiotensin II.","date":"2013","source":"Hypertension (Dallas, Tex. : 1979)","url":"https://pubmed.ncbi.nlm.nih.gov/24019400","citation_count":50,"is_preprint":false},{"pmid":"21610494","id":"PMC_21610494","title":"Role of SPAK and OSR1 signalling in the regulation of NaCl cotransporters.","date":"2011","source":"Current opinion in nephrology and hypertension","url":"https://pubmed.ncbi.nlm.nih.gov/21610494","citation_count":49,"is_preprint":false},{"pmid":"20223824","id":"PMC_20223824","title":"Multiple pathways for protein phosphatase 1 (PP1) regulation of Na-K-2Cl cotransporter (NKCC1) function: the N-terminal tail of the Na-K-2Cl cotransporter serves as a regulatory scaffold for Ste20-related proline/alanine-rich kinase (SPAK) AND PP1.","date":"2010","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/20223824","citation_count":49,"is_preprint":false},{"pmid":"20385770","id":"PMC_20385770","title":"SORLA/SORL1 functionally interacts with SPAK to control renal activation of Na(+)-K(+)-Cl(-) cotransporter 2.","date":"2010","source":"Molecular and cellular biology","url":"https://pubmed.ncbi.nlm.nih.gov/20385770","citation_count":46,"is_preprint":false},{"pmid":"23739593","id":"PMC_23739593","title":"Aldosterone acutely stimulates NCC activity via a SPAK-mediated pathway.","date":"2013","source":"American journal of physiology. Renal physiology","url":"https://pubmed.ncbi.nlm.nih.gov/23739593","citation_count":46,"is_preprint":false},{"pmid":"18348195","id":"PMC_18348195","title":"An analysis of candidate autism loci on chromosome 2q24-q33: evidence for association to the STK39 gene.","date":"2008","source":"American journal of medical genetics. Part B, Neuropsychiatric genetics : the official publication of the International Society of Psychiatric Genetics","url":"https://pubmed.ncbi.nlm.nih.gov/18348195","citation_count":43,"is_preprint":false},{"pmid":"22294159","id":"PMC_22294159","title":"Effect of heterozygous deletion of WNK1 on the WNK-OSR1/ SPAK-NCC/NKCC1/NKCC2 signal cascade in the kidney and blood vessels.","date":"2012","source":"Clinical and experimental nephrology","url":"https://pubmed.ncbi.nlm.nih.gov/22294159","citation_count":43,"is_preprint":false},{"pmid":"31165006","id":"PMC_31165006","title":"The WNK-SPAK/OSR1 Kinases and the Cation-Chloride Cotransporters as Therapeutic Targets for Neurological Diseases.","date":"2019","source":"Aging and disease","url":"https://pubmed.ncbi.nlm.nih.gov/31165006","citation_count":42,"is_preprint":false},{"pmid":"33192599","id":"PMC_33192599","title":"Physiological Processes Modulated by the Chloride-Sensitive WNK-SPAK/OSR1 Kinase Signaling Pathway and the Cation-Coupled Chloride Cotransporters.","date":"2020","source":"Frontiers in physiology","url":"https://pubmed.ncbi.nlm.nih.gov/33192599","citation_count":41,"is_preprint":false},{"pmid":"25086033","id":"PMC_25086033","title":"Hypotonicity stimulates potassium flux through the WNK-SPAK/OSR1 kinase cascade and the Ncc69 sodium-potassium-2-chloride cotransporter in the Drosophila renal tubule.","date":"2014","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/25086033","citation_count":40,"is_preprint":false},{"pmid":"16530727","id":"PMC_16530727","title":"The TNF receptor, RELT, binds SPAK and uses it to mediate p38 and JNK activation.","date":"2006","source":"Biochemical and biophysical research communications","url":"https://pubmed.ncbi.nlm.nih.gov/16530727","citation_count":40,"is_preprint":false},{"pmid":"28371477","id":"PMC_28371477","title":"Rafoxanide and Closantel Inhibit SPAK and OSR1 Kinases by Binding to a Highly Conserved Allosteric Site on Their C-terminal Domains.","date":"2017","source":"ChemMedChem","url":"https://pubmed.ncbi.nlm.nih.gov/28371477","citation_count":38,"is_preprint":false},{"pmid":"11514053","id":"PMC_11514053","title":"Androgens induce expression of SPAK, a STE20/SPS1-related kinase, in LNCaP human prostate cancer cells.","date":"2001","source":"Molecular and cellular endocrinology","url":"https://pubmed.ncbi.nlm.nih.gov/11514053","citation_count":36,"is_preprint":false},{"pmid":"22846565","id":"PMC_22846565","title":"Phosphorylation of Na-Cl cotransporter by OSR1 and SPAK kinases regulates its ubiquitination.","date":"2012","source":"Biochemical and biophysical research communications","url":"https://pubmed.ncbi.nlm.nih.gov/22846565","citation_count":36,"is_preprint":false},{"pmid":"29848507","id":"PMC_29848507","title":"The Calcium-Sensing Receptor Increases Activity of the Renal NCC through the WNK4-SPAK Pathway.","date":"2018","source":"Journal of the American Society of Nephrology : JASN","url":"https://pubmed.ncbi.nlm.nih.gov/29848507","citation_count":35,"is_preprint":false},{"pmid":"24811174","id":"PMC_24811174","title":"A novel Ste20-related proline/alanine-rich kinase (SPAK)-independent pathway involving calcium-binding protein 39 (Cab39) and serine threonine kinase with no lysine member 4 (WNK4) in the activation of Na-K-Cl cotransporters.","date":"2014","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/24811174","citation_count":35,"is_preprint":false},{"pmid":"33500714","id":"PMC_33500714","title":"STK39 is a novel kinase contributing to the progression of hepatocellular carcinoma by the PLK1/ERK signaling pathway.","date":"2021","source":"Theranostics","url":"https://pubmed.ncbi.nlm.nih.gov/33500714","citation_count":34,"is_preprint":false},{"pmid":"23235437","id":"PMC_23235437","title":"Enhanced FGF23 serum concentrations and phosphaturia in gene targeted mice expressing WNK-resistant SPAK.","date":"2012","source":"Kidney & blood pressure research","url":"https://pubmed.ncbi.nlm.nih.gov/23235437","citation_count":34,"is_preprint":false},{"pmid":"21088576","id":"PMC_21088576","title":"SPAK and WNK kinases: a new target for blood pressure treatment?","date":"2011","source":"Current opinion in nephrology and hypertension","url":"https://pubmed.ncbi.nlm.nih.gov/21088576","citation_count":34,"is_preprint":false},{"pmid":"23044422","id":"PMC_23044422","title":"WNK-OSR1/SPAK-NCC signal cascade has circadian rhythm dependent on aldosterone.","date":"2012","source":"Biochemical and biophysical research communications","url":"https://pubmed.ncbi.nlm.nih.gov/23044422","citation_count":33,"is_preprint":false},{"pmid":"26861815","id":"PMC_26861815","title":"Deletion of the WNK3-SPAK kinase complex in mice improves radiographic and clinical outcomes in malignant cerebral edema after ischemic stroke.","date":"2016","source":"Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism","url":"https://pubmed.ncbi.nlm.nih.gov/26861815","citation_count":33,"is_preprint":false},{"pmid":"25994507","id":"PMC_25994507","title":"Critical role of the SPAK protein kinase CCT domain in controlling blood pressure.","date":"2015","source":"Human molecular genetics","url":"https://pubmed.ncbi.nlm.nih.gov/25994507","citation_count":32,"is_preprint":false},{"pmid":"23026752","id":"PMC_23026752","title":"The WNK/SPAK and IRBIT/PP1 pathways in epithelial fluid and electrolyte transport.","date":"2012","source":"Physiology (Bethesda, Md.)","url":"https://pubmed.ncbi.nlm.nih.gov/23026752","citation_count":31,"is_preprint":false},{"pmid":"23499375","id":"PMC_23499375","title":"Knockout of Ste20-like proline/alanine-rich kinase (SPAK) attenuates intestinal inflammation in mice.","date":"2013","source":"The American journal of pathology","url":"https://pubmed.ncbi.nlm.nih.gov/23499375","citation_count":30,"is_preprint":false},{"pmid":"22415098","id":"PMC_22415098","title":"WNK3-SPAK interaction is required for the modulation of NCC and other members of the SLC12 family.","date":"2012","source":"Cellular physiology and biochemistry : international journal of experimental cellular physiology, biochemistry, and pharmacology","url":"https://pubmed.ncbi.nlm.nih.gov/22415098","citation_count":30,"is_preprint":false},{"pmid":"23427142","id":"PMC_23427142","title":"Loss of WNK3 is compensated for by the WNK1/SPAK axis in the kidney of the mouse.","date":"2013","source":"American journal of physiology. Renal physiology","url":"https://pubmed.ncbi.nlm.nih.gov/23427142","citation_count":30,"is_preprint":false},{"pmid":"18550547","id":"PMC_18550547","title":"PKCdelta acts upstream of SPAK in the activation of NKCC1 by hyperosmotic stress in human airway epithelial cells.","date":"2008","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/18550547","citation_count":29,"is_preprint":false},{"pmid":"22238094","id":"PMC_22238094","title":"Kinases SPAK and OSR1 are upregulated by estradiol and activate NKCC1 in the developing hypothalamus.","date":"2012","source":"The Journal of neuroscience : the official journal of the Society for Neuroscience","url":"https://pubmed.ncbi.nlm.nih.gov/22238094","citation_count":27,"is_preprint":false},{"pmid":"32589890","id":"PMC_32589890","title":"Activated WNK3 induced by intracerebral hemorrhage deteriorates brain injury maybe via WNK3/SPAK/NKCC1 pathway.","date":"2020","source":"Experimental neurology","url":"https://pubmed.ncbi.nlm.nih.gov/32589890","citation_count":27,"is_preprint":false},{"pmid":"24808538","id":"PMC_24808538","title":"Novel mechanisms of Na+ retention in obesity: phosphorylation of NKCC2 and regulation of SPAK/OSR1 by AMPK.","date":"2014","source":"American journal of physiology. Renal physiology","url":"https://pubmed.ncbi.nlm.nih.gov/24808538","citation_count":27,"is_preprint":false},{"pmid":"25531585","id":"PMC_25531585","title":"Negative regulation of the creatine transporter SLC6A8 by SPAK and OSR1.","date":"2014","source":"Kidney & blood pressure research","url":"https://pubmed.ncbi.nlm.nih.gov/25531585","citation_count":27,"is_preprint":false},{"pmid":"19343169","id":"PMC_19343169","title":"Ste20-related proline/alanine-rich kinase (SPAK) regulated transcriptionally by hyperosmolarity is involved in intestinal barrier function.","date":"2009","source":"PloS one","url":"https://pubmed.ncbi.nlm.nih.gov/19343169","citation_count":26,"is_preprint":false},{"pmid":"28943960","id":"PMC_28943960","title":"STK39, overexpressed in osteosarcoma, regulates osteosarcoma cell invasion and proliferation.","date":"2017","source":"Oncology letters","url":"https://pubmed.ncbi.nlm.nih.gov/28943960","citation_count":25,"is_preprint":false},{"pmid":"38353402","id":"PMC_38353402","title":"Modulation of Cerebrospinal Fluid Dysregulation via a SPAK and OSR1 Targeted Framework Nucleic Acid in Hydrocephalus.","date":"2024","source":"Advanced science (Weinheim, Baden-Wurttemberg, Germany)","url":"https://pubmed.ncbi.nlm.nih.gov/38353402","citation_count":25,"is_preprint":false},{"pmid":"34374638","id":"PMC_34374638","title":"Knockdown of long non-coding RNA CDKN2B-AS1 suppresses the progression of breast cancer by miR-122-5p/STK39 axis.","date":"2021","source":"Bioengineered","url":"https://pubmed.ncbi.nlm.nih.gov/34374638","citation_count":25,"is_preprint":false},{"pmid":"35413993","id":"PMC_35413993","title":"Role of SPAK-NKCC1 signaling cascade in the choroid plexus blood-CSF barrier damage after stroke.","date":"2022","source":"Journal of neuroinflammation","url":"https://pubmed.ncbi.nlm.nih.gov/35413993","citation_count":25,"is_preprint":false},{"pmid":"32724175","id":"PMC_32724175","title":"WNK-SPAK/OSR1-NCC kinase signaling pathway as a novel target for the treatment of salt-sensitive hypertension.","date":"2020","source":"Acta pharmacologica Sinica","url":"https://pubmed.ncbi.nlm.nih.gov/32724175","citation_count":24,"is_preprint":false},{"pmid":"25323061","id":"PMC_25323061","title":"Regulation of ClC-2 activity by SPAK and OSR1.","date":"2014","source":"Kidney & blood pressure research","url":"https://pubmed.ncbi.nlm.nih.gov/25323061","citation_count":24,"is_preprint":false},{"pmid":"23527223","id":"PMC_23527223","title":"STK39 polymorphism is associated with essential hypertension: a systematic review and meta-analysis.","date":"2013","source":"PloS one","url":"https://pubmed.ncbi.nlm.nih.gov/23527223","citation_count":23,"is_preprint":false},{"pmid":"30723251","id":"PMC_30723251","title":"The interplay of renal potassium and sodium handling in blood pressure regulation: critical role of the WNK-SPAK-NCC pathway.","date":"2019","source":"Journal of human hypertension","url":"https://pubmed.ncbi.nlm.nih.gov/30723251","citation_count":23,"is_preprint":false},{"pmid":"25376088","id":"PMC_25376088","title":"SPAK dependent regulation of peptide transporters PEPT1 and PEPT2.","date":"2014","source":"Kidney & blood pressure research","url":"https://pubmed.ncbi.nlm.nih.gov/25376088","citation_count":23,"is_preprint":false},{"pmid":"25322850","id":"PMC_25322850","title":"SPAK and OSR1 dependent down-regulation of murine renal outer medullary K channel ROMK1.","date":"2014","source":"Kidney & blood pressure research","url":"https://pubmed.ncbi.nlm.nih.gov/25322850","citation_count":23,"is_preprint":false},{"pmid":"31085334","id":"PMC_31085334","title":"Suppression of WNK1-SPAK/OSR1 Attenuates Bone Cancer Pain by Regulating NKCC1 and KCC2.","date":"2019","source":"The journal of pain","url":"https://pubmed.ncbi.nlm.nih.gov/31085334","citation_count":22,"is_preprint":false},{"pmid":"35272484","id":"PMC_35272484","title":"NF-κB Signaling-Mediated Activation of WNK-SPAK-NKCC1 Cascade in Worsened Stroke Outcomes of Ang II-Hypertensive Mice.","date":"2022","source":"Stroke","url":"https://pubmed.ncbi.nlm.nih.gov/35272484","citation_count":22,"is_preprint":false},{"pmid":"31786261","id":"PMC_31786261","title":"WNK4-SPAK modulates lipopolysaccharide-induced macrophage activation.","date":"2019","source":"Biochemical pharmacology","url":"https://pubmed.ncbi.nlm.nih.gov/31786261","citation_count":22,"is_preprint":false},{"pmid":"29923766","id":"PMC_29923766","title":"WNK-SPAK/OSR1 signaling: lessons learned from an insect renal epithelium.","date":"2018","source":"American journal of physiology. Renal physiology","url":"https://pubmed.ncbi.nlm.nih.gov/29923766","citation_count":22,"is_preprint":false},{"pmid":"25477470","id":"PMC_25477470","title":"STE20/SPS1-related proline/alanine-rich kinase (SPAK) is critical for sodium reabsorption in isolated, perfused thick ascending limb.","date":"2014","source":"American journal of physiology. Renal physiology","url":"https://pubmed.ncbi.nlm.nih.gov/25477470","citation_count":21,"is_preprint":false},{"pmid":"33719576","id":"PMC_33719576","title":"Roles of WNK4 and SPAK in K+-mediated dephosphorylation of the NaCl cotransporter.","date":"2021","source":"American journal of physiology. Renal physiology","url":"https://pubmed.ncbi.nlm.nih.gov/33719576","citation_count":20,"is_preprint":false},{"pmid":"19717643","id":"PMC_19717643","title":"Epigenetic silencing of Stk39 in B-cell lymphoma inhibits apoptosis from genotoxic stress.","date":"2009","source":"The American journal of pathology","url":"https://pubmed.ncbi.nlm.nih.gov/19717643","citation_count":20,"is_preprint":false},{"pmid":"26208601","id":"PMC_26208601","title":"Domain-Swapping Switch Point in Ste20 Protein Kinase SPAK.","date":"2015","source":"Biochemistry","url":"https://pubmed.ncbi.nlm.nih.gov/26208601","citation_count":19,"is_preprint":false},{"pmid":"27519267","id":"PMC_27519267","title":"SPAK plays a pathogenic role in IgA nephropathy through the activation of NF-κB/MAPKs signaling pathway.","date":"2016","source":"Free radical biology & medicine","url":"https://pubmed.ncbi.nlm.nih.gov/27519267","citation_count":19,"is_preprint":false},{"pmid":"34335956","id":"PMC_34335956","title":"STK39 promotes breast cancer invasion and metastasis by increasing SNAI1 activity upon phosphorylation.","date":"2021","source":"Theranostics","url":"https://pubmed.ncbi.nlm.nih.gov/34335956","citation_count":18,"is_preprint":false},{"pmid":"35932362","id":"PMC_35932362","title":"MiR-223-3p-loaded exosomes from bronchoalveolar lavage fluid promote alveolar macrophage autophagy and reduce acute lung injury by inhibiting the expression of STK39.","date":"2022","source":"Human cell","url":"https://pubmed.ncbi.nlm.nih.gov/35932362","citation_count":18,"is_preprint":false},{"pmid":"20006650","id":"PMC_20006650","title":"Behavioral analysis of Ste20 kinase SPAK knockout mice.","date":"2009","source":"Behavioural brain research","url":"https://pubmed.ncbi.nlm.nih.gov/20006650","citation_count":18,"is_preprint":false}],"cost":{"stage1":{"model":"claude-sonnet-4-6","input_tokens":56217,"output_tokens":9124,"usd":0.152755},"stage2":{"model":"claude-opus-4-6","input_tokens":12998,"output_tokens":3709,"usd":0.236572},"total_usd":0.389327,"stage1_batch_id":"msgbatch_01RPbVc9PDH9zQmYK5Hs6srm","stage2_batch_id":"msgbatch_01JVbVLzeKN2yVrsGp3zC8aM","note":"batch pricing = 50% of standard"},"stage1_raw":"```json\n{\n  \"discoveries\": [\n    {\n      \"year\": 2000,\n      \"finding\": \"SPAK (STK39) is a serine/threonine kinase that can autophosphorylate and phosphorylate exogenous substrates in vitro; it specifically activates the p38 MAPK pathway in cotransfection assays; full-length SPAK localizes to the cytoplasm while a caspase-cleaved form localizes predominantly to the nucleus.\",\n      \"method\": \"In vitro kinase assay, cotransfection/reporter assay, subcellular localization by immunofluorescence\",\n      \"journal\": \"Oncogene\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — in vitro kinase activity plus functional cotransfection and localization data, single lab\",\n      \"pmids\": [\"10980603\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2002,\n      \"finding\": \"SPAK and OSR1 directly interact with cation-chloride cotransporters KCC3, NKCC1, and NKCC2 (but not KCC1 or KCC4) via a conserved C-terminal domain on the kinases that recognizes an (R/K)FX(V/I) binding motif on the cotransporters; co-immunoprecipitation confirmed the SPAK-NKCC1 interaction in mouse brain.\",\n      \"method\": \"Yeast two-hybrid, GST pulldown, co-immunoprecipitation, immunohistochemistry\",\n      \"journal\": \"The Journal of biological chemistry\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — reciprocal interaction confirmed by multiple methods (Y2H, pulldown, Co-IP) in multiple contexts; replicated widely\",\n      \"pmids\": [\"12386165\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2003,\n      \"finding\": \"SPAK acts as a scaffolding protein at NKCC1: preventing SPAK binding to NKCC1 does not affect basal cotransporter function, but SPAK co-immunoprecipitates with p38 MAPK and NKCC1 in an activity-dependent manner, with p38 dissociating from the complex upon cellular stress while SPAK-NKCC1 interaction remains stable.\",\n      \"method\": \"86Rb+ uptake assay in Xenopus oocytes, co-immunoprecipitation, Western blot\",\n      \"journal\": \"The Journal of biological chemistry\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — functional and biochemical data from single lab with multiple methods\",\n      \"pmids\": [\"14563843\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2004,\n      \"finding\": \"PKCθ phosphorylates SPAK on Ser-311 in its kinase domain; SPAK interacts with PKCθ (but not PKCα) via its C-terminal 99 residues; TCR/CD28 costimulation enhances this association and SPAK kinase activity; SPAK synergizes with constitutively active PKCθ to activate AP-1 but not NF-κB in T cells.\",\n      \"method\": \"Co-immunoprecipitation, in vitro kinase assay, RNAi knockdown, reporter assay\",\n      \"journal\": \"The EMBO journal\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1-2 — direct phosphorylation site identified by mutagenesis plus Co-IP and functional reporter assays, moderate evidence\",\n      \"pmids\": [\"14988727\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2005,\n      \"finding\": \"WNK1 phosphorylates the evolutionary conserved serine residue located outside the kinase domain of SPAK (and OSR1), and this phosphorylation influences SPAK/OSR1 kinase activity; SPAK and OSR1 directly phosphorylate the N-terminal regulatory regions of cation-chloride cotransporters NKCC1, NKCC2, and NCC; hypotonic stress activates SPAK/OSR1 and induces cotransporter phosphorylation.\",\n      \"method\": \"In vitro kinase assay, cell-based phosphorylation assay, site-directed mutagenesis\",\n      \"journal\": \"The Journal of biological chemistry\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 — direct in vitro phosphorylation with mutagenesis, widely replicated\",\n      \"pmids\": [\"16263722\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2006,\n      \"finding\": \"SPAK activation loop residues T243 and T247 are required for kinase activity; mutation of T243A or T247A produces a dominant-negative effect on NKCC1 activity in Xenopus oocytes; OSR1 has similar kinase properties and activates NKCC1 when coexpressed with WNK4.\",\n      \"method\": \"Site-directed mutagenesis, 32P-ATP in vitro phosphorylation, 86Rb+ uptake in Xenopus oocytes\",\n      \"journal\": \"Molecular and cellular biology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 — activation-loop mutagenesis combined with in vitro and functional assays\",\n      \"pmids\": [\"16382158\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2006,\n      \"finding\": \"SPAK and OSR1 possess a conserved C-terminal CCT domain that interacts with nanomolar affinity with RFXV motifs in substrates (NKCC1) and upstream activators (WNK1/WNK4); specific residues within the CCT domain are required for RFXV binding; an intact CCT domain is required for WNK1 to efficiently phosphorylate and activate OSR1; SPAK/OSR1 phosphorylate NKCC1 at Thr203/Thr207/Thr212 (human) identified by in vitro assay.\",\n      \"method\": \"In vitro kinase assay, surface plasmon resonance, CCT domain mutagenesis, peptide competition\",\n      \"journal\": \"The Biochemical journal\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 — reconstitution with quantitative binding measurements and mutagenesis; replicated across multiple labs\",\n      \"pmids\": [\"16669787\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2006,\n      \"finding\": \"RELT (TNF receptor) binds SPAK via an RFRV motif and uses SPAK to mediate p38 and JNK activation; disruption of the SPAK binding motif in RELT or use of kinase-dead SPAK inhibits RELT-induced p38/JNK activation.\",\n      \"method\": \"Yeast two-hybrid, co-immunoprecipitation, reporter/kinase activity assay\",\n      \"journal\": \"Biochemical and biophysical research communications\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 3 — single Co-IP plus functional assay, single lab\",\n      \"pmids\": [\"16530727\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2007,\n      \"finding\": \"Physical docking of SPAK to NKCC1 via a single RFXV binding motif is necessary for cotransporter activation; mutation of the phenylalanine in the motif abolishes binding and activation; SPAK phosphorylates NKCC1 at T206 and T211 as major regulatory sites.\",\n      \"method\": \"Yeast two-hybrid, 32P-ATP in vitro phosphorylation, 86Rb+ uptake in Xenopus oocytes, site-directed mutagenesis\",\n      \"journal\": \"Cellular physiology and biochemistry\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 — phosphorylation site identification combined with docking mutagenesis and functional assay\",\n      \"pmids\": [\"17595523\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2007,\n      \"finding\": \"AATYK1 scaffolds protein phosphatase 1 (PP1) via a PP1 docking motif and binds SPAK via RFXV motifs; AATYK1 inhibits NKCC1 activity by bringing PP1 into proximity with SPAK, thereby indirectly opposing SPAK/WNK4 activation of the cotransporter.\",\n      \"method\": \"Yeast two-hybrid, 86Rb+ uptake in Xenopus oocytes, site-directed mutagenesis\",\n      \"journal\": \"American journal of physiology. Cell physiology\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — functional assay with mutagenesis plus protein-protein interaction data, single lab\",\n      \"pmids\": [\"17267545\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2008,\n      \"finding\": \"SPAK and OSR1 activated by WNK1 phosphorylate human NCC at Thr46, Thr55, and Thr60; efficient NCC phosphorylation requires a docking interaction between an RFXI motif in NCC and SPAK/OSR1; hypotonic low-chloride conditions activate the WNK1-SPAK/OSR1 pathway to phosphorylate NCC in kidney cells.\",\n      \"method\": \"In vitro kinase assay, phospho-specific antibodies, cell-based assay in HEK293 and mpkDCT cells, mutagenesis\",\n      \"journal\": \"Journal of cell science\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 — direct phosphorylation sites mapped by mutagenesis and in vitro assay, replicated in cells\",\n      \"pmids\": [\"18270262\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2008,\n      \"finding\": \"PKCδ acts upstream of SPAK to activate NKCC1 during hyperosmotic stress in airway epithelial cells; PKCδ directly binds SPAK and phosphorylates it to increase SPAK kinase activity; SPAK binds the amino terminus of NKCC1 directly and SPAK knockdown prevents NKCC1 phosphorylation and activation.\",\n      \"method\": \"siRNA knockdown, recombinant protein binding assay, in vitro kinase assay, 86Rb+ flux assay, co-immunoprecipitation\",\n      \"journal\": \"The Journal of biological chemistry\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1-2 — direct binding and in vitro kinase data plus RNAi functional validation with multiple methods\",\n      \"pmids\": [\"18550547\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2009,\n      \"finding\": \"STK39/SPAK interacts with WNK kinases and cation-chloride cotransporters in vivo; STK39 is expressed in the distal nephron where it may regulate renal Na+ excretion; an intronic conserved element shows allele-specific transcriptional activity, suggesting BP-associated variants increase STK39 expression.\",\n      \"method\": \"Cell-based co-immunoprecipitation, in vivo expression/localization, in vitro transcription reporter assay\",\n      \"journal\": \"Proceedings of the National Academy of Sciences of the United States of America\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2-3 — Co-IP interaction confirmed, localization established, functional transcription element tested; single study\",\n      \"pmids\": [\"19114657\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2009,\n      \"finding\": \"AngII signaling increases NCC activity via a WNK4-SPAK-dependent pathway in Xenopus oocytes and mammalian cells; dominant-negative SPAK or elimination of the SPAK binding motif in NCC prevents AngII-mediated NCC activation; AngII increases phosphorylation of specific activation sites on SPAK and NCC.\",\n      \"method\": \"Xenopus oocyte expression, dominant-negative SPAK, phospho-specific antibodies in mpkDCT cells\",\n      \"journal\": \"Proceedings of the National Academy of Sciences of the United States of America\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — epistasis with dominant-negative plus cell-based phosphorylation, replicated in two expression systems\",\n      \"pmids\": [\"19240212\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2009,\n      \"finding\": \"Epigenetic silencing of STK39 in B-cell lymphoma inhibits caspase-3-dependent apoptosis from DNA double-strand breaks; SPAK knockdown by shRNA protects B cells from genotoxic stress-induced apoptosis but not osmotic/oxidative stress; c-Jun N-terminal kinase (JNK) is a potential downstream mediator of SPAK in this pathway.\",\n      \"method\": \"shRNA knockdown, apoptosis/caspase-3 assay, pharmacological JNK inhibition, DNA methylation analysis\",\n      \"journal\": \"The American journal of pathology\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — RNAi loss-of-function with specific apoptosis readout and pathway pharmacology, single lab\",\n      \"pmids\": [\"19717643\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2010,\n      \"finding\": \"SPAK knockout mice exhibit hypotension with Gitelman syndrome phenotype (hypokalemia, hypomagnesemia, hypocalciuria); NCC phosphorylation and expression are markedly reduced while NKCC2 phosphorylation is increased; NKCC1 phosphorylation in aortic tissue is decreased causing impaired vasoconstriction, establishing SPAK as an in vivo regulator of both renal NCC and vascular NKCC1.\",\n      \"method\": \"SPAK-null mouse model, phospho-specific Western blot, diuretic challenge, vascular contractility assay\",\n      \"journal\": \"Journal of the American Society of Nephrology : JASN\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — clean knockout with multiple defined phenotypic readouts, replicated by multiple labs\",\n      \"pmids\": [\"20813865\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2010,\n      \"finding\": \"SPAK knock-in mice in which SPAK cannot be activated by WNK kinases display markedly reduced phosphorylation and expression of NCC and NKCC2 cotransporters and significantly reduced blood pressure, establishing the WNK-SPAK axis as the key in vivo regulatory pathway for these transporters.\",\n      \"method\": \"Knock-in mouse model (WNK-binding site mutation), phospho-specific Western blot, blood pressure measurement\",\n      \"journal\": \"EMBO molecular medicine\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — genetic epistasis with clean knock-in, replicated phenotype across multiple groups\",\n      \"pmids\": [\"20091762\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2010,\n      \"finding\": \"SPAK requires phosphorylation at T243 (catalytic domain) and S383 (regulatory domain) by WNK kinases for activation; mutating S383 to alanine or surrounding residues paradoxically renders SPAK constitutively active; a second catalytic-domain serine S321 can also be phosphorylated by WNK4; SPAK substrate recognition requires two threonines separated by four amino acids with a hydrophobic residue after the first.\",\n      \"method\": \"Site-directed mutagenesis, 86Rb+ uptake in Xenopus oocytes, in vitro kinase assay\",\n      \"journal\": \"American journal of physiology. Cell physiology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 — detailed mechanistic mutagenesis combined with functional and in vitro assays\",\n      \"pmids\": [\"20463172\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2010,\n      \"finding\": \"PP1 dephosphorylates both SPAK and the N-terminal tail of NKCC1 directly; the PP1 binding motif on NKCC1 facilitates scaffolding of PP1 near SPAK, greatly enhancing PP1-mediated dephosphorylation of SPAK.\",\n      \"method\": \"In vitro dephosphorylation assay with recombinant proteins, 86Rb+ uptake in Xenopus oocytes, mutagenesis\",\n      \"journal\": \"The Journal of biological chemistry\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 1 — in vitro reconstitution with recombinant proteins plus functional oocyte assay, single lab\",\n      \"pmids\": [\"20223824\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2010,\n      \"finding\": \"SORLA intracellular sorting receptor functionally interacts with SPAK and controls SPAK intracellular trafficking; SORLA deficiency results in missorting of SPAK and consequent failure to phosphorylate NKCC2 in the thick ascending limb.\",\n      \"method\": \"Co-immunoprecipitation, SORLA knockout mouse model, phospho-specific Western blot, immunofluorescence\",\n      \"journal\": \"Molecular and cellular biology\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — binding and knockout model with defined molecular phenotype, single lab\",\n      \"pmids\": [\"20385770\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2011,\n      \"finding\": \"MO25α/β bind SPAK/OSR1 and induce ~100-fold activation of their kinase activity, dramatically enhancing phosphorylation of ion cotransporters NKCC1, NKCC2, and NCC; siRNA-mediated MO25 reduction inhibits endogenous NKCC1 phosphorylation at SPAK/OSR1 sites.\",\n      \"method\": \"In vitro kinase assay, siRNA knockdown, phospho-specific Western blot, surface plasmon resonance\",\n      \"journal\": \"The EMBO journal\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1-2 — large activation magnitude in vitro, confirmed in cells with RNAi rescue; multiple orthogonal methods\",\n      \"pmids\": [\"21423148\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2011,\n      \"finding\": \"WNK kinases act as scaffolds to recruit SPAK, which phosphorylates CFTR and NBCe1-B to reduce their cell surface expression in pancreatic ductal epithelium; IRBIT opposes WNK/SPAK effects by recruiting PP1 to dephosphorylate CFTR and NBCe1-B; silencing SPAK increases ductal secretion.\",\n      \"method\": \"siRNA knockdown in mouse pancreatic ducts, cell surface biotinylation, phosphorylation assay, rescue experiments\",\n      \"journal\": \"The Journal of clinical investigation\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — multiple orthogonal methods with epistasis rescue in intact tissue, single lab\",\n      \"pmids\": [\"21317537\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2011,\n      \"finding\": \"A kidney-specific truncated SPAK isoform lacking the kinase domain inhibits full-length SPAK-mediated phosphorylation of NCC and NKCC2 in vitro; SPAK knockout has divergent effects along TAL (increased pNKCC2) and DCT (decreased pNCC), explained by differential isoform expression along the nephron.\",\n      \"method\": \"In vitro kinase assay, SPAK knockout mouse model, isoform-specific Western blot and immunofluorescence\",\n      \"journal\": \"Cell metabolism\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1-2 — in vitro isoform inhibition combined with clean knockout phenotyping, validated across multiple labs\",\n      \"pmids\": [\"21907141\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2012,\n      \"finding\": \"SPAK and OSR1 directly phosphorylate all KCC isoforms at a conserved C-terminal threonine (Site-2, Thr1048 in KCC3A) to promote their inhibition; WNK pathway inhibition suppresses this phosphorylation; cells lacking SPAK/OSR1 activity have elevated KCC3A activity; a Site-2 alanine KCC3A mutant shows increased activity.\",\n      \"method\": \"In vitro kinase assay with recombinant proteins, SPAK/OSR1 double-knockin ES cells, 86Rb+ uptake, WNK pathway inhibitor\",\n      \"journal\": \"The Biochemical journal\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 — reconstituted in vitro, confirmed in genetic cell model with multiple readouts\",\n      \"pmids\": [\"24393035\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2012,\n      \"finding\": \"SPAK/OSR1 double-knockin ES cells (where SPAK/OSR1 cannot be activated by WNK) show abolished NKCC1 phosphorylation and activation, providing genetic evidence that NKCC1 is strictly dependent on SPAK/OSR1 activity; WNK1 and WNK3 activity is markedly elevated in knockin cells, revealing a feedback where downstream SPAK/OSR1 influence upstream WNK activity.\",\n      \"method\": \"Double-knockin ES cell model, 86Rb+ uptake, phospho-specific Western blot\",\n      \"journal\": \"The Biochemical journal\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — genetic epistasis in ES cells with multiple readouts, single lab but rigorous design\",\n      \"pmids\": [\"22032326\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2012,\n      \"finding\": \"In the DCT, OSR1 is dependent on SPAK for apical membrane localization and activity; in SPAK knockout mice, OSR1 becomes largely inactive and redistributes from the apical membrane to cytoplasmic WNK1-containing puncta, causing loss of NCC phosphorylation specifically in DCT1.\",\n      \"method\": \"SPAK knockout mouse model, immunofluorescence, phospho-specific Western blot, subcellular fractionation\",\n      \"journal\": \"The Journal of biological chemistry\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — clean knockout with defined localization and phosphorylation phenotype\",\n      \"pmids\": [\"22977235\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2012,\n      \"finding\": \"PI3K/Akt signaling activates the WNK-OSR1/SPAK-NCC phosphorylation cascade in hyperinsulinemic db/db mice; this is evidenced by PI3K inhibitors correcting increased OSR1/SPAK and NCC phosphorylation, and by genetic knockin mice (SpakT243A/+ and Osr1T185A/+) completely correcting increased NCC phosphorylation and elevated blood pressure in db/db mice.\",\n      \"method\": \"Knockin mouse genetics, pharmacological PI3K/Akt inhibition, phospho-specific Western blot\",\n      \"journal\": \"Hypertension\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — genetic epistasis with knockin plus pharmacological inhibition, cross-validated\",\n      \"pmids\": [\"22949526\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2012,\n      \"finding\": \"ASK3 interacts with WNK1 and suppresses the WNK1-SPAK/OSR1 signaling pathway; Ask3 knockout mice display hyperactivation of SPAK/OSR1 in renal tubules and hypertension.\",\n      \"method\": \"Co-immunoprecipitation, siRNA knockdown, Ask3 knockout mouse model, phospho-specific Western blot, blood pressure measurement\",\n      \"journal\": \"Nature communications\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — genetic knockout with pathway activation readout plus biochemical interaction, single lab\",\n      \"pmids\": [\"23250415\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2013,\n      \"finding\": \"SPAK phosphorylates NBCe1-B at Ser65 and IRBIT/PP1 at Thr49 to regulate the Na+-HCO3- cotransporter; IRBIT and PIP2 activate NBCe1-B by a convergent non-additive mechanism, with SPAK phosphorylation setting the inhibitory resting state.\",\n      \"method\": \"In vitro phosphorylation, mutagenesis, functional transport assay in Xenopus oocytes\",\n      \"journal\": \"Proceedings of the National Academy of Sciences of the United States of America\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 1-2 — direct phosphorylation site identification with functional mutagenesis, single lab\",\n      \"pmids\": [\"23431199\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2013,\n      \"finding\": \"Aldosterone acutely stimulates SPAK phosphorylation in the distal convoluted tubule, which increases NCC phosphorylation and activity without changing total NCC abundance; gene silencing of SPAK eliminates the aldosterone effect on NCC activity; the effect is also SGK1-dependent.\",\n      \"method\": \"siRNA knockdown of SPAK in mpkDCT cells, phospho-specific Western blot, 22Na+ uptake assay, adrenalectomized rodent model\",\n      \"journal\": \"American journal of physiology. Renal physiology\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — genetic knockdown with functional transport assay in cells and in vivo confirmation, single lab\",\n      \"pmids\": [\"23739593\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2014,\n      \"finding\": \"WNK4 in association with the scaffold protein Cab39 can activate NKCC1 in a SPAK/OSR1-independent manner; WNK4 possesses a PF2-like domain homologous to the SPAK/OSR1 CCT domain that mediates direct interaction with NKCC1, allowing WNK4 to anchor to the N-terminal domain of NKCC1 and promote cotransporter activation.\",\n      \"method\": \"Xenopus oocyte expression, yeast two-hybrid, homology modeling, 86Rb+ uptake, mutagenesis\",\n      \"journal\": \"The Journal of biological chemistry\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — multiple binding and functional assays but single lab\",\n      \"pmids\": [\"24811174\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2015,\n      \"finding\": \"The CCT domain Leu502 residue of SPAK is essential for interaction with RFXV/I motifs in WNK1, NCC, and NKCC2; CCT domain L502A knock-in mice abolish these co-immunoprecipitation interactions, show markedly reduced SPAK kinase activity and NCC/NKCC2 phosphorylation, and display Gitelman syndrome features with reduced blood pressure.\",\n      \"method\": \"Knock-in mouse genetics, co-immunoprecipitation, phospho-specific Western blot, blood pressure/electrolyte measurement\",\n      \"journal\": \"Human molecular genetics\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — genetic knock-in with defined docking mutation, multiple readouts, physiological confirmation\",\n      \"pmids\": [\"25994507\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2015,\n      \"finding\": \"Crystal structures of SPAK kinase domain (SPAK 63-403 at 3.1 Å and T243D mutant at 2.5 Å) reveal domain-swapped dimer conformations; a monomeric SPAK mutant retains kinase activity and is activated by WNK1 but shows reduced phosphorylation of NKCC2, indicating domain swapping modulates substrate access rather than intrinsic catalysis.\",\n      \"method\": \"X-ray crystallography, site-directed mutagenesis, in vitro kinase assay\",\n      \"journal\": \"Biochemistry\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 — crystal structures combined with mutagenesis and functional kinase assay\",\n      \"pmids\": [\"26208601\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2017,\n      \"finding\": \"Constitutively active SPAK (kinase-activating mutation in Stk39) expressed specifically in the DCT causes thiazide-treatable hypertension and hyperkalemia with NCC hyperphosphorylation; CA-SPAK drives ASDN remodeling with reduced connecting tubule mass and decreased ENaC and ROMK apical expression, revealing a DCT-ASDN structural coupling mechanism.\",\n      \"method\": \"Conditional knock-in mouse with DCT-specific Cre, phospho-specific Western blot, immunofluorescence, thiazide challenge\",\n      \"journal\": \"Journal of the American Society of Nephrology : JASN\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — conditional kinase-activating knockin with defined structural and functional phenotypes\",\n      \"pmids\": [\"28442491\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2017,\n      \"finding\": \"Allosteric inhibitors (rafoxanide, closantel) bind a conserved pocket on the C-terminal domains of SPAK and OSR1, distinct from the ATP-binding site, and inhibit kinase activity by targeting this allosteric site.\",\n      \"method\": \"In silico screening, in vitro kinase assay, binding studies\",\n      \"journal\": \"ChemMedChem\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 3 — allosteric site identification by in silico and in vitro assay, single lab\",\n      \"pmids\": [\"28371477\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2019,\n      \"finding\": \"WNK4 is the primary active WNK isoform in WNK bodies (spherical cytoplasmic condensates in DCT) and catalyzes SPAK/OSR1 phosphorylation therein; phosphorylated SPAK/OSR1 is present both at the apical membrane and in WNK bodies during K+ deprivation; WNK body formation requires Kir4.1-dependent K+ sensing in the DCT.\",\n      \"method\": \"Immunofluorescence in WNK4-deficient and Kir4.1-conditional KO mice, phospho-specific antibodies, dietary manipulation\",\n      \"journal\": \"American journal of physiology. Renal physiology\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — genetic mouse models with localization and phosphorylation readouts, single lab\",\n      \"pmids\": [\"31736353\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2020,\n      \"finding\": \"The SPAK inhibitor ZT-1a (5-chloro-N-(5-chloro-4-((4-chlorophenyl)(cyano)methyl)-2-methylphenyl)-2-hydroxybenzamide) decreases SPAK-dependent phosphorylation of NKCC1 and simultaneously stimulates KCCs by reducing their SPAK-dependent phosphorylation; intracerebroventricular ZT-1a reduces CSF hypersecretion in post-hemorrhagic hydrocephalus; systemic ZT-1a reduces ischemia-induced CCC phosphorylation and cerebral edema in stroke.\",\n      \"method\": \"In vitro kinase assay, rodent stroke/hydrocephalus models, CCC phosphorylation assay, pharmacological inhibition\",\n      \"journal\": \"Nature communications\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1-2 — in vitro target engagement plus multiple in vivo disease models with defined molecular readouts\",\n      \"pmids\": [\"31911626\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2021,\n      \"finding\": \"STK39 interacts with and phosphorylates SNAI1 at T203, promoting SNAI1 nuclear retention and stability in breast cancer cells; STK39 inhibition destabilizes SNAI1, impairs EMT, and reduces tumor cell migration, invasion, and metastasis in vitro and in vivo.\",\n      \"method\": \"Co-immunoprecipitation, in vitro kinase/phosphorylation assay, subcellular fractionation, knockdown/overexpression functional assays, xenograft model\",\n      \"journal\": \"Theranostics\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — direct phosphorylation site identified with multiple functional readouts, single lab\",\n      \"pmids\": [\"34335956\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2021,\n      \"finding\": \"STK39 binds PLK1 (identified by mass spectrometry) and promotes HCC progression by activating the ERK signaling pathway in a PLK1-dependent manner; STK39 knockdown arrests cells in G2/M and promotes apoptosis.\",\n      \"method\": \"Mass spectrometry, co-immunoprecipitation, RNA-seq, siRNA knockdown, cell cycle and apoptosis assays\",\n      \"journal\": \"Theranostics\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2-3 — MS-identified interaction with functional validation, single lab\",\n      \"pmids\": [\"33500714\"],\n      \"is_preprint\": false\n    }\n  ],\n  \"current_model\": \"STK39/SPAK is a STE20-family serine/threonine kinase that is activated by WNK kinases (via phosphorylation of its T-loop Thr243 and regulatory Ser383) and by the scaffold MO25, and that in turn directly phosphorylates and stimulates Na+-driven cation-chloride cotransporters (NKCC1, NKCC2, NCC) while simultaneously phosphorylating and inhibiting K+-driven KCC family members at conserved C-terminal threonine residues; substrate recognition and upstream activation both depend on a conserved C-terminal CCT domain that docks RFXV/I motifs on WNKs and cotransporters, and this WNK-SPAK axis is the primary in vivo regulator of renal salt reabsorption, vascular tone, and neuronal Cl- homeostasis, with additional roles in T-cell AP-1 signaling (via PKCθ), epithelial HCO3- secretion (via CFTR/NBCe1-B phosphorylation), and cancer cell invasion (via SNAI1 phosphorylation at T203).\"\n}\n```","stage2_raw":"```json\n{\n  \"mechanistic_narrative\": \"STK39 (SPAK) is a STE20-family serine/threonine kinase that functions as the central effector of the WNK signaling cascade to regulate ion homeostasis in kidney, vasculature, and brain. WNK kinases phosphorylate SPAK at T-loop residue T243 and regulatory S383, and the scaffold MO25 further amplifies SPAK activity ~100-fold; activated SPAK then directly phosphorylates N-terminal threonines on Na⁺-coupled cation-chloride cotransporters NKCC1, NKCC2, and NCC to stimulate their activity, while simultaneously phosphorylating a conserved C-terminal threonine on KCC family members to inhibit them [PMID:16263722, PMID:21423148, PMID:24393035]. Substrate recognition and upstream docking both require the conserved C-terminal CCT domain, which binds RFXV/I motifs on WNKs and cotransporters with nanomolar affinity [PMID:16669787, PMID:25994507]. SPAK knockout or WNK-binding-deficient knock-in mice develop a Gitelman-like syndrome with reduced blood pressure, establishing SPAK as the primary in vivo regulator of renal salt reabsorption and vascular tone, with additional roles in epithelial HCO₃⁻ secretion via CFTR/NBCe1-B phosphorylation, T-cell AP-1 signaling via PKCθ, and cancer cell invasion via SNAI1 phosphorylation [PMID:20813865, PMID:20091762, PMID:21317537, PMID:14988727, PMID:34335956].\",\n  \"teleology\": [\n    {\n      \"year\": 2000,\n      \"claim\": \"Establishing that SPAK is an active kinase capable of autophosphorylation and exogenous substrate phosphorylation resolved the basic question of whether STK39 encodes a functional kinase, and its activation of p38 MAPK placed it in a stress-signaling context.\",\n      \"evidence\": \"In vitro kinase assay and cotransfection reporter assays in mammalian cells\",\n      \"pmids\": [\"10980603\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Physiological substrates unidentified\", \"p38 activation mechanism unclear (direct vs. indirect)\", \"Upstream activator unknown\"]\n    },\n    {\n      \"year\": 2002,\n      \"claim\": \"Discovery that SPAK directly binds cation-chloride cotransporters NKCC1, NKCC2, and KCC3 via a C-terminal domain recognizing RFXV/I motifs identified the first physiological substrate class and the docking mechanism, fundamentally redirecting the field from stress-kinase signaling to ion transport regulation.\",\n      \"evidence\": \"Yeast two-hybrid, GST pulldown, co-immunoprecipitation from mouse brain\",\n      \"pmids\": [\"12386165\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Whether SPAK phosphorylates these cotransporters was not yet shown\", \"Identity of upstream activating kinase unknown\"]\n    },\n    {\n      \"year\": 2004,\n      \"claim\": \"Identification of PKCθ as an upstream kinase phosphorylating SPAK at S311 and the demonstration that SPAK activates AP-1 in T cells established a non-ion-transport signaling role and the first upstream phosphorylation event on SPAK.\",\n      \"evidence\": \"Co-immunoprecipitation, in vitro kinase assay, RNAi, reporter assay in T cells\",\n      \"pmids\": [\"14988727\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Whether this PKCθ-SPAK axis operates on cotransporters unknown\", \"Relationship to WNK signaling unclear\"]\n    },\n    {\n      \"year\": 2005,\n      \"claim\": \"The pivotal discovery that WNK1 phosphorylates SPAK and that SPAK/OSR1 in turn directly phosphorylate the N-terminal regulatory regions of NKCC1, NKCC2, and NCC established the WNK→SPAK→CCC phosphorylation cascade as a coherent signaling pathway governing cation-chloride cotransport.\",\n      \"evidence\": \"In vitro kinase assay with site-directed mutagenesis, cell-based phosphorylation assays\",\n      \"pmids\": [\"16263722\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Specific phosphosites on cotransporters not yet mapped\", \"In vivo relevance unconfirmed\"]\n    },\n    {\n      \"year\": 2006,\n      \"claim\": \"Detailed characterization of the CCT domain's nanomolar-affinity RFXV-motif binding, identification of activation-loop residues T243/T247 as essential for catalysis, and mapping of NKCC1 phosphorylation sites (T203/T207/T212) provided the structural and biochemical framework for SPAK substrate recognition and activation.\",\n      \"evidence\": \"Surface plasmon resonance, X-ray-guided mutagenesis, 86Rb⁺ uptake in Xenopus oocytes, in vitro kinase assays\",\n      \"pmids\": [\"16669787\", \"16382158\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Full crystal structure of CCT-RFXV complex not yet solved\", \"Regulation of SPAK by scaffolds other than WNK unknown\"]\n    },\n    {\n      \"year\": 2008,\n      \"claim\": \"Extension of the WNK-SPAK cascade to NCC (mapping phosphosites T46/T55/T60) and demonstration that PKCδ also activates SPAK during osmotic stress broadened the upstream inputs and downstream substrates of the pathway beyond NKCC1.\",\n      \"evidence\": \"In vitro kinase assay with phospho-specific antibodies in kidney cells; siRNA and 86Rb⁺ flux in airway epithelia\",\n      \"pmids\": [\"18270262\", \"18550547\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"In vivo significance of PKCδ-SPAK axis unconfirmed\", \"Relative contributions of SPAK vs. OSR1 to NCC regulation unknown\"]\n    },\n    {\n      \"year\": 2010,\n      \"claim\": \"SPAK knockout and WNK-binding-deficient knock-in mice provided definitive in vivo proof that SPAK is the essential kinase for NCC phosphorylation, regulates NKCC1-dependent vascular tone, and controls blood pressure, producing a Gitelman-like phenotype with hypotension.\",\n      \"evidence\": \"SPAK-null and knock-in mouse models with phospho-Western, blood pressure, and vascular contractility assays\",\n      \"pmids\": [\"20813865\", \"20091762\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Compensatory OSR1 effects not fully dissected\", \"Tissue-specific isoform contributions unclear\"]\n    },\n    {\n      \"year\": 2011,\n      \"claim\": \"Discovery that MO25 activates SPAK ~100-fold and that a kidney-specific truncated SPAK isoform acts as a dominant-negative inhibitor explained how SPAK activity is fine-tuned and why SPAK knockout has divergent effects on NCC vs. NKCC2 phosphorylation along the nephron.\",\n      \"evidence\": \"In vitro kinase assay with MO25, siRNA, SPAK knockout mouse with isoform-specific analysis\",\n      \"pmids\": [\"21423148\", \"21907141\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"How MO25 binding is regulated in vivo unknown\", \"Whether truncated isoform has independent functions unclear\"]\n    },\n    {\n      \"year\": 2012,\n      \"claim\": \"Demonstration that SPAK/OSR1 phosphorylate KCC family members at a conserved C-terminal threonine to inhibit them established that SPAK reciprocally regulates Na⁺-importing (NKCC/NCC activated) and K⁺-exporting (KCC inhibited) cotransporters, unifying chloride homeostasis under one kinase.\",\n      \"evidence\": \"In vitro kinase assay, SPAK/OSR1 double-knockin ES cells, 86Rb⁺ uptake\",\n      \"pmids\": [\"24393035\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"In vivo KCC phosphorylation by SPAK not yet confirmed in genetic models\", \"Contribution to neuronal Cl⁻ homeostasis inferred but not directly tested\"]\n    },\n    {\n      \"year\": 2012,\n      \"claim\": \"Genetic epistasis in PI3K/Akt-hyperactive db/db mice showed that insulin signaling activates the WNK-SPAK-NCC cascade, and SPAK-inactivating knock-in completely rescued hypertension, linking metabolic syndrome to SPAK-dependent salt retention.\",\n      \"evidence\": \"SpakT243A/+ knock-in crossed with db/db mice, PI3K inhibitor, phospho-Western\",\n      \"pmids\": [\"22949526\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Direct phosphorylation link between Akt and WNK not established\", \"Translation to human metabolic hypertension unconfirmed\"]\n    },\n    {\n      \"year\": 2015,\n      \"claim\": \"Crystal structures of the SPAK kinase domain revealed domain-swapped dimers that modulate substrate access rather than intrinsic catalysis, and CCT domain L502A knock-in mice confirmed that a single docking residue is essential for all RFXV-dependent interactions in vivo.\",\n      \"evidence\": \"X-ray crystallography at 2.5–3.1 Å resolution; L502A knock-in mice with Co-IP, phospho-Western, blood pressure\",\n      \"pmids\": [\"26208601\", \"25994507\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Full-length SPAK structure not available\", \"Whether dimerization occurs in cells undemonstrated\"]\n    },\n    {\n      \"year\": 2017,\n      \"claim\": \"DCT-specific constitutively active SPAK knock-in mice developed thiazide-sensitive hypertension with hyperkalemia and ASDN remodeling, proving that SPAK activation in a single nephron segment is sufficient to drive systemic blood pressure elevation and revealing DCT-ASDN structural coupling.\",\n      \"evidence\": \"Conditional CA-SPAK knock-in with DCT-specific Cre, immunofluorescence, thiazide challenge\",\n      \"pmids\": [\"28442491\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Molecular signals mediating ASDN remodeling downstream of SPAK unknown\", \"Whether CA-SPAK also alters KCC phosphorylation in vivo not tested\"]\n    },\n    {\n      \"year\": 2020,\n      \"claim\": \"The SPAK inhibitor ZT-1a demonstrated that pharmacological SPAK inhibition simultaneously reduces NKCC1 phosphorylation and relieves KCC inhibition in vivo, attenuating cerebral edema and CSF hypersecretion, validating SPAK as a druggable target for neurological fluid disorders.\",\n      \"evidence\": \"In vitro kinase assay, rodent stroke and hydrocephalus models with CCC phosphorylation readouts\",\n      \"pmids\": [\"31911626\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Off-target effects of ZT-1a not fully profiled\", \"Long-term safety and specificity in vivo unknown\"]\n    },\n    {\n      \"year\": 2021,\n      \"claim\": \"Identification of SNAI1 as a SPAK substrate phosphorylated at T203, promoting SNAI1 nuclear retention and EMT in breast cancer, extended SPAK's substrate repertoire beyond ion transport to transcription factor regulation and cancer metastasis.\",\n      \"evidence\": \"Co-immunoprecipitation, in vitro kinase assay, knockdown/overexpression, xenograft model\",\n      \"pmids\": [\"34335956\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Whether SNAI1 phosphorylation depends on the CCT-RFXV docking mechanism is untested\", \"Relevance to other cancer types unknown\", \"Independent replication needed\"]\n    },\n    {\n      \"year\": null,\n      \"claim\": \"Key unresolved questions include the full-length SPAK structure with CCT domain and MO25, the molecular basis of SPAK dimerization in cells, the relative tissue-specific contributions of SPAK vs. OSR1, the mechanism by which SPAK regulates cell cycle and apoptosis independently of ion transport, and whether SPAK inhibitors can be developed for safe clinical use in hypertension and neurological disorders.\",\n      \"evidence\": \"\",\n      \"pmids\": [],\n      \"confidence\": \"Low\",\n      \"gaps\": [\"No full-length SPAK structure available\", \"SPAK vs. OSR1 tissue-specific redundancy not genetically resolved in all organs\", \"Cancer and cell-cycle roles lack mechanistic depth\"]\n    }\n  ],\n  \"mechanism_profile\": {\n    \"molecular_activity\": [\n      {\"term_id\": \"GO:0140096\", \"supporting_discovery_ids\": [0, 4, 5, 6, 8, 10, 17, 20, 23, 37]},\n      {\"term_id\": \"GO:0098772\", \"supporting_discovery_ids\": [22, 23]}\n    ],\n    \"localization\": [\n      {\"term_id\": \"GO:0005829\", \"supporting_discovery_ids\": [0, 35]},\n      {\"term_id\": \"GO:0005634\", \"supporting_discovery_ids\": [0]},\n      {\"term_id\": \"GO:0005886\", \"supporting_discovery_ids\": [25, 35]}\n    ],\n    \"pathway\": [\n      {\"term_id\": \"R-HSA-382551\", \"supporting_discovery_ids\": [1, 4, 8, 10, 15, 16, 23, 36]},\n      {\"term_id\": \"R-HSA-162582\", \"supporting_discovery_ids\": [3, 13, 26, 27]},\n      {\"term_id\": \"R-HSA-168256\", \"supporting_discovery_ids\": [3]},\n      {\"term_id\": \"R-HSA-1643685\", \"supporting_discovery_ids\": [37, 38]}\n    ],\n    \"complexes\": [],\n    \"partners\": [\n      \"WNK1\",\n      \"WNK4\",\n      \"OXSR1\",\n      \"SLC12A2\",\n      \"SLC12A3\",\n      \"SLC12A1\",\n      \"CAB39\",\n      \"PRKCQ\"\n    ],\n    \"other_free_text\": []\n  }\n}\n```"}